Explorez tous les épisodes du podcast Medical Device made Easy Podcast

Small Business, Smart Start: AI Without Complex Infrastructure

Artificial Intelligence is creating new opportunities for businesses to improve productivity, simplify workflows, and reduce repetitive administrative work.

However, for many small medical device companies, adopting AI can feel overwhelming.

Where should you begin? Which processes are worth automating? Do you need expensive infrastructure or a dedicated development team? And how can you ensure that an AI assistant delivers reliable results?

In this episode of Medical Device Made Easy, we welcome Helder Conceicao to explore how small businesses can take their first practical steps with AI agents.

With experience in service engineering, business processes, and supporting AI adoption in small companies, Helder brings a practical perspective to a topic that is often presented as more complicated than it needs to be.

Understanding AI Agents: Beyond Traditional Chatbots

Many professionals have already experimented with AI tools to answer questions, draft emails, or summarize information.

But an AI agent introduces a different way of thinking about how AI can support business processes.

Rather than focusing only on individual conversations, the discussion explores how AI assistants can support defined tasks and workflows.

Helder explains the differences between traditional chatbots and AI agents, including what these solutions can accomplish and where human involvement remains necessary.

The objective is to help business owners understand the practical possibilities before investing in a solution.

Choosing the Right First AI Project

One of the biggest challenges in AI adoption is deciding where to begin.

Businesses may have dozens of processes that could potentially benefit from automation, but not every task is a good starting point.

The conversation explores how to identify a first project based on a genuine operational need.

For medical device companies, potential areas to investigate include:

Documentation: Supporting document preparation, organization, and information retrieval.

Quality and Regulatory Affairs: Assisting with administrative activities and information management while maintaining appropriate human review.

Field Service: Exploring ways to support service-related workflows and routine processes.

The key is to identify a manageable use case with a clear purpose and measurable value.

From an Idea to a Working AI Assistant

Once a company has identified a suitable process, what happens next?

The episode explores the journey from an initial business problem to a functioning AI solution.

This includes understanding what information the company needs to prepare, how the workflow should operate, and what technical resources may be required.

An important part of the discussion is determining whether an existing AI platform can meet the company's needs or whether additional development and infrastructure are necessary.

For smaller organizations, these decisions can have a significant impact on project complexity, cost, and implementation time.

How Much Does AI Implementation Really Require?

Cost and resources are common concerns for businesses considering AI.

Does every AI project require a large budget? How much time should the company expect to invest? And how involved does the internal team need to be?

Helder discusses the practical considerations behind planning an AI implementation, including the importance of defining the project's scope and understanding the resources required.

The goal is to help businesses approach AI adoption with realistic expectations rather than assuming that every solution requires a major technology investment.

Keeping Humans in Control

For medical device companies, automation must be considered alongside reliability, accountability, and appropriate oversight.

Not every task should be delegated to AI without review.

The conversation addresses how to determine which activities an AI assistant can support independently and which require a qualified person to review, approve, or make the final decision.

It also explores how businesses can test whether an AI assistant is sufficiently reliable for its intended task, particularly when working with important company documents.

AI should support better business processes without removing necessary human judgment and responsibility.

Measuring the Value of Your First AI Project

Implementing an AI assistant is only the beginning.

The next question is whether the solution actually improves the business process it was designed to support.

The discussion examines common challenges encountered during initial AI projects and how businesses can evaluate their results.

Potential considerations include time saved, reduced repetitive work, improved workflow efficiency, and the level of human intervention still required.

Understanding these outcomes can help a company decide whether to improve its first solution or move toward another use case.

Building Independence and Long-Term Capability

An AI solution should not necessarily leave a company dependent on the person who originally developed it.

The episode also explores the importance of documentation, knowledge transfer, and ongoing support.

Helder discusses how businesses can understand the solutions implemented for them, how they may operate those solutions independently, and what additional assistance could be available after deployment.

This is particularly relevant for small companies that want to develop their internal capabilities while keeping their technology manageable.

Final Takeaway: Start Small, Learn, and Expand

AI adoption doesn't have to begin with a company-wide transformation.

For small medical device businesses, a useful first step is to identify one process that consumes time, creates repetitive work, or could benefit from better information management.

Then explore whether an AI assistant can help.

Start with a clear problem. Build a focused solution. Test the results. Keep people involved where necessary. Measure the value.

Once the first project demonstrates its usefulness, the company can consider what comes next.

In this episode of Medical Device Made Easy, Helder Conceicao helps make the first steps toward AI adoption more understandable and practical for small businesses.

What is one business task you would like AI to help you improve?

Who is Helder Conceição?

Helder Conceição is the founder of heconexus®, helping small businesses in Portugal adopt AI in their everyday work. He brings more than 25 years of experience at Johnson & Johnson across local, European and global roles, spanning service engineering, business processes and digital initiatives. His approach focuses on practical processes, measurable value, human oversight and helping teams become confident and autonomous in their use of AI.

Links

LinkedIn: https://www.linkedin.com/in/helderconceicao/ 

AI in SMEs: where to start improving everyday work

https://www.linkedin.com/pulse/ia-nas-pmes-por-onde-começar-para-melhorar-o-trabalho-conceição-bptae/

 choosing a useful first process, testing with the team and measuring value.

Which AI is best for your company?

https://www.linkedin.com/feed/update/urn:li:activity:7514233631742164992/

 choosing a platform around a real business task and the company’s needs.

One successful AI example: is that enough for the team to start using it?

https://www.linkedin.com/feed/update/urn:li:activity:7510972255170994176/

testing varied cases, checking sources and defining human review.

Social Media to follow

Monir El Azzouzi Linkedin: https://linkedin.com/in/melazzouzi

Twitter: https://twitter.com/elazzouzim

Pinterest: https://www.pinterest.com/easymedicaldevice

Instagram: https://www.instagram.com/easymedicaldevice

This podcast is hosted by Podcastics, the easiest platform to create and publish your podcast.

October brings another important round of regulatory developments for the medical device and IVD industry. From updated IVD classification guidance in Europe and potential changes to the UK medical device licensing framework, to new FDA expectations for robotically assisted surgical devices, radiology AI, PMA submissions, and international regulatory reliance, manufacturers have several developments worth following closely.

Here is our Medical Device Regulatory Update for October 2026, supported by regulatory intelligence from MedBoard.

🇪🇺 European Union – Revised IVD Classification Guidance

The European Commission has published MDCG 2020-16 Rev.5, updating the guidance on classification rules for in vitro diagnostic medical devices under the IVDR.

For IVD manufacturers, classification is a fundamental regulatory decision that can affect the conformity assessment route and regulatory strategy.

👉 MDCG 2020-16 Rev.5 – Guidance on Classification Rules for IVDs

🇬🇧 UK – The Door Opens to Direct MHRA Licensing

Proposed amendments to the UK Government's Health Bill could create powers supporting the future development of a medical device licensing regime.

The amendments also address information-sharing powers for medicines and medical devices and measures intended to make medicines and medical-device legislation easier to update.

This is an important development to watch for manufacturers planning access to the UK market.

👉 MHRA Regulatory Reform Amendments – Health Bill

🇬🇧 MHRA Warning – Incompatible Components Continue to Cause Serious Incidents

The MHRA has highlighted ongoing safety concerns involving patient hoists and incompatible components.

The warning is an important reminder that medical-device safety does not stop with individual component compliance. Compatibility between components, accessories and systems can directly affect patient safety.

Manufacturers and healthcare organizations should pay close attention to compatibility information, instructions for use and the way devices are combined in real-world environments.

👉 MHRA – Steps to Prevent Avoidable Harm from Patient Hoists

🇨🇭 swissdamed – Importer Linking Is Now Operational

Another important development comes from Switzerland.

Swiss importers can now link their CHRN to imported devices in swissdamed.

This adds another operational consideration for manufacturers and importers working in the Swiss medical-device market, particularly as swissdamed becomes increasingly important within the country's regulatory infrastructure.

👉 Swissmedic – Information for Importers in swissdamed

🌍 Rest of the World

🇺🇸 FDA – Robotically Assisted Surgical Devices

The FDA has issued draft guidance addressing robotically assisted surgical devices.

The guidance covers areas including non-clinical testing, clinical evidence and labeling for teleoperated surgical systems.

For manufacturers developing robotic surgical technologies, understanding these expectations early can help inform development, testing and premarket strategy.

👉 FDA – Robotically Assisted Surgical Devices: Premarket Submissions

🤖 FDA Rejects Proposed 510(k) Exemption for Radiology AI Devices

AI remains firmly on the regulatory agenda.

The FDA has rejected a proposed exemption from premarket notification for certain radiology computer-aided detection, diagnosis and triage devices.

The practical message for manufacturers is clear: these products must continue to obtain the applicable FDA clearance before being marketed.

👉 FDA – Radiology Computer-Aided Detection, Diagnosis and Triage Devices

🇺🇸 FDA Moves PMA Applications Toward Structured Electronic Submissions

The FDA is also moving toward a more structured approach to electronic Premarket Approval (PMA) applications.

Draft guidance introduces electronic resources and templates intended to improve submission consistency and review efficiency.

Manufacturers working on PMA submissions should follow this development as electronic submission structures continue to evolve.

👉 FDA – Electronic Submission Template for PMA Applications

🌐 FDA Creates a Regulatory Reliance Resource Centre

International regulatory reliance continues to gain attention.

The FDA has created a dedicated CDRH Regulatory Reliance Portal explaining how other regulatory authorities can leverage FDA regulatory work and decisions while retaining their own national sovereignty and decision-making responsibilities.

For an increasingly global medical-device industry, regulatory reliance could play an important role in reducing unnecessary duplication and supporting more efficient regulatory processes.

👉 FDA CDRH Regulatory Reliance Portal

🛠️ What's New at Easy Medical Device?

Alongside this month's regulatory developments, Easy Medical Device continues to expand the resources and services available to medical-device companies.

EasyIFU

EasyIFU supports medical-device manufacturers working with electronic Instructions for Use.

👉 Discover EasyIFU

New Partner Services

New partner services are also available in areas including:

Software Development & Cybersecurity

Company Creation

These services expand the support available to medical-device companies across different stages of their development and market-access journey.

🎙️ Latest Easy Medical Device Podcast Episodes

October is also a good opportunity to catch up on the latest Medical Device Made Easy episodes.

Episode 406 – Your Technical Documentation Has All the Documents… So Why Isn't It Ready?

Having every document does not necessarily mean your Technical Documentation is assessment-ready. This episode explores adequacy, consistency, evidence and traceability across the dossier.

👉 Listen to Episode 406

Episode 407 – Why Management Doesn't Listen to Quality and How to Change That

Why do Quality and Regulatory teams sometimes become isolated from the rest of the organization? This episode explores the shift from being the “Quality Police” to becoming a Quality Influencer.

👉 Listen to Episode 407

Episode 408 – Vertical Slicing for Complex SaMD Development

Complex SaMD development can become fragmented when teams focus on individual components. This conversation explores vertical slicing as a way to look at functionality and clinical workflows end-to-end.

👉 Listen to Episode 408

Episode 409 – AI Is Already Inside Your QMS – But Is It Under Control?

AI may already be used by Quality, Regulatory, Engineering and PMS teams—even without a formal company-wide AI initiative.

This episode discusses Shadow AI, risk-based AI control, verification, human accountability and how Quality teams can approach AI without simply banning it.

👉 Listen to Episode 409

This podcast is hosted by Podcastics, the easiest platform to create and publish your podcast.

Artificial Intelligence may already be part of your Quality Management System, even if your organization has never formally implemented an AI tool.

Regulatory Affairs professionals may use ChatGPT to research requirements. Quality teams may use AI to help draft procedures or summarize meetings. Engineers may ask AI to brainstorm potential failure modes. Post-Market Surveillance teams may experiment with AI to analyze complaints.

This creates an important challenge:

AI may already be inside your QMS—even though your QMS doesn't know it. Markdown collé

The answer isn't necessarily to ban AI.

The answer is to understand where it is being used and introduce controls proportionate to the risk.

The Shadow AI Problem

Employees don't always wait for management to formally implement AI.

When a tool can turn a three-hour activity into a thirty-minute task, people naturally become interested.

The Quality challenge isn't simply that AI is being used. The problem is that the organization may not know:

what activities AI supports, what information employees provide to it, how outputs are verified, and how heavily people rely on those outputs.

This is what the episode describes as Shadow AI. Markdown collé

Not Every AI Use Has the Same Risk

Asking AI to improve the wording of an email isn't equivalent to asking it to determine whether complaint data indicates a safety signal.

The key question is:

What happens if the AI is wrong?

An error in a rewritten email may have limited consequences. An incorrect conclusion about complaint reportability or patient safety could have significantly different consequences.

AI governance should therefore be based on intended use and risk, rather than treating every AI application identically. Markdown collé

Green, Amber, Red: A Practical AI Framework

The episode introduces a simple traffic-light approach.

🟢 Green — Assist

AI improves productivity without materially driving a regulated decision.

Examples include improving English, formatting documents, brainstorming, summarizing meeting notes or helping structure a presentation.

Normal human review, together with appropriate confidentiality and information-security controls, may be sufficient for these lower-risk applications.

🟠 Amber — Verify

AI begins influencing regulated work.

Examples include helping draft an SOP, suggesting potential FMEA failure modes, summarizing complaints, researching regulatory requirements or suggesting possible CAPA root causes.

The principle here is simple:

AI can propose. A qualified person must verify.

AI can help locate information, but it shouldn't automatically become the regulatory evidence supporting a decision.

🔴 Red — Assess Before Deployment

Here, AI makes or materially drives a critical decision.

Examples could include automatically determining complaint reportability, accepting suppliers, closing CAPAs, deciding risk acceptability or generating clinical conclusions without independent qualified evaluation.

These uses call for formal assessment before the organization relies on the system. Markdown collé

Human Review Is Not Automatically Verification

“We have a human reviewing everything” sounds reassuring.

But what does review actually mean?

Generative AI can produce incorrect information that looks professional and convincing. Reading an AI-generated regulatory assessment and thinking “looks good” isn't necessarily meaningful verification.

The episode proposes another important principle:

Trust the source, not the sentence.

Regulatory requirements should be checked against the regulation. Complaint-analysis results should be checked against the underlying data and methodology. Technical suggestions should be evaluated by qualified personnel. Markdown collé

Five Steps for Bringing AI Under Control

Rather than immediately writing an AI SOP, the episode recommends starting with discovery.

First, inventory where AI is already being used.

Then classify each use according to what could happen if the output is wrong.

Next, control the input, particularly where patient information, complaints, confidential drawings, clinical data, intellectual property or supplier information may be involved.

After that, define how the output will be verified.

Finally, maintain human accountability.

As the episode puts it:

“AI can perform work. It cannot inherit your regulatory accountability.” Markdown collé

What About AI Validation?

Instead of starting with:

“Do we need to validate ChatGPT?”

Start by asking:

What exactly are we using it for?

Then:

What happens if it gives us the wrong answer?

And finally:

What level of assurance do we need for that intended use?

The framework presented in the episode is:

Intended Use → Risk → Control → Evidence. Markdown collé

AI Literacy Matters Too

AI governance isn't only about procedures and technical controls.

People need to understand what AI does well, where it can fail, how errors and hallucinations can occur, how information should be verified, what data they are allowed to enter, and when AI should not be relied upon.

That's a much more practical form of AI literacy than simply asking employees to click through another annual training presentation. Markdown collé

AI Isn't the Enemy of Quality

The message of the episode isn't to avoid AI.

Quite the opposite.

AI could create significant opportunities for Quality and Regulatory teams—from supporting complaint analysis and regulatory intelligence to identifying recurring CAPA themes, simplifying procedures, creating training exercises, checking Technical Documentation for inconsistencies, and brainstorming potential hazards for qualified professionals to assess. Markdown collé

The role of Quality shouldn't be to stand in front of innovation and say:

“No, because compliance.”

It should be to enable innovation with appropriate controls.

Final Takeaway

Instead of asking your team:

“Are you using ChatGPT?”

Ask:

“Show me where AI is helping you do your job today.”

Then build the inventory and ask what happens if the AI gets each task wrong.

Green: Assist.
Amber: Verify.
Red: Assess before deployment.

Control the inputs. Verify the outputs. Keep humans accountable.

Because banning AI may not stop its use, while ignoring it means losing visibility.

A better approach is:

Understand it. Control it. Use it. Markdown collé

Social Media to follow

Monir El Azzouzi Linkedin: https://linkedin.com/in/melazzouzi

Twitter: https://twitter.com/elazzouzim

Pinterest: https://www.pinterest.com/easymedicaldevice

Instagram: https://www.instagram.com/easymedicaldevice

This podcast is hosted by Podcastics, the easiest platform to create and publish your podcast.

Developing complex Software as a Medical Device (SaMD) can quickly become challenging.

Requirements, software architecture, dependencies, risk management, verification, regulatory evidence, and cross-functional collaboration all need to work together.

But what happens when individual software components appear to work correctly while the complete end-to-end workflow reveals something different?

In this episode of the Easy Medical Device Podcast, Monir El Azzouzi welcomes Shreya Sridhar from Medtronic to explore vertical slicing for complex regulated software products.

Rather than looking at a system only through individual components or technical layers, vertical slicing provides a way to examine functionality end-to-end.

In this episode, we discuss:

🔹 What vertical slicing means in practice
🔹 The challenges of developing complex SaMD
🔹 How end-to-end workflows can reveal hidden problems
🔹 How to structure vertical slices
🔹 Integrating vertical slicing into Agile development
🔹 Risk management, verification, and regulatory evidence
🔹 Vertical slicing alongside Design Controls
🔹 Cross-functional collaboration in regulated development
🔹 What “Done” means for a vertical slice in a medical device environment
🔹 The potential role of vertical slicing as AI supports requirements, code, testing, and documentation
🔹 Practical advice for teams that want to start using the approach

The conversation connects software development with the realities of regulated medical device development, looking beyond whether individual components work to understand whether the complete functionality works as intended.

Who is Shreya Sridhar?

Shreya Sridhar is a Principal Systems Engineer and technical leader specializing in complex Software as a Medical Device (SaMD) and AI-enabled medical technologies. Her work focuses on systems architecture, requirements, risk management, verification, and cross-functional product development. She has published and presented on systems engineering, vertical slicing, and the development of complex regulated software, with a particular focus on connecting product strategy to end-to-end engineering execution.   

Who is Monir El Azzouzi? 

Monir El Azzouzi is the founder and CEO of Easy Medical Device a Consulting firm that is supporting Medical Device manufacturers for any Quality and Regulatory affairs activities all over the world. Monir can help you to create your Quality Management System, Technical Documentation or he can also take care of your Clinical Evaluation, Clinical Investigation through his team or partners. Easy Medical Device can also become your Authorized Representative and Independent Importer Service provider for EU, UK and Switzerland. 

Monir has around 16 years of experience within the Medical Device industry working for small businesses and also big corporate companies. He has now supported around 100 clients to remain compliant on the market. His passion to the Medical Device filed pushed him to create educative contents like, blog, podcast, YouTube videos, LinkedIn Lives where he invites guests who are sharing educative information to his audience. Visit easymedicaldevice.com to know more.  If you need help implementing QMSR or preparing your teams for FDA inspections, contact: info@easymedicaldevice.com

 If you are located outside the EU/UK/Switzerland and need an Authorized Representative (and possibly an Importer), we can support you as well.

Links

Shreya LinkedIn: https://www.linkedin.com/in/shreyasridhar/ 

Links to Articles on Vertical Slicing: 

1. Designing SaMD for safety and rethinking risk management through system architecture 

2. Decomposing Complexity: A Systems Engineering View of Modern Software — Aligning the V-Model with a Slicing-Based Decomposition Strategy 

3. Your roadmap is not a feature list: A two-level slicing framework for better release planning 

4. Vertical Slicing as a Foundation for SaMD Development in the Age of Agentic AI 

Social Media to follow

Monir El Azzouzi Linkedin: https://linkedin.com/in/melazzouzi

Twitter: https://twitter.com/elazzouzim

Pinterest: https://www.pinterest.com/easymedicaldevice

Instagram: https://www.instagram.com/easymedicaldevice

This podcast is hosted by Podcastics, the easiest platform to create and publish your podcast.

Quality and Regulatory professionals often find themselves in a frustrating position.

They identify a problem, explain the compliance risk and recommend an action. But instead of being seen as protecting the organization, they can become perceived as the people creating obstacles.

Operations sees a delayed project. Finance sees additional resources. Management sees another problem that needs to be solved.

Over time, this dynamic can leave QA/RA professionals frustrated, isolated and exhausted.

But the problem isn't always management.

Sometimes, the way Quality operates can unintentionally contribute to that isolation.

When Quality Owns Everything

Consider a nonconformity that occurs in Production.

In some organizations, Quality opens the record, writes the description, gathers the evidence, conducts much of the investigation, pushes for the root cause, proposes the corrective action and follows the issue until closure.

The problem happened in Production—but Quality performed almost all the work.

The organization eventually learns a dangerous lesson:

“When something goes wrong, send it to Quality.”

This creates dependency instead of ownership.

A better principle is:

Ownership stays with the process owner. Quality provides the framework and the challenge.

The Quality Tyrant, Invisible Manager and Influencer

Under pressure, QA/RA professionals can fall into three different behaviours.

The Quality Tyrant tries to create compliance through control. They take over investigations, impose solutions and attempt to own every decision.

The Invisible Quality Manager moves in the opposite direction. They avoid difficult conversations, accept weak justifications and may close issues before they have been properly understood.

The Quality Influencer takes a different approach.

They involve the people closest to the process, separate facts from assumptions, challenge weak root causes, verify that actions address the actual problem and keep responsibility with the process owner.

Quality Shouldn't Be the Human Shield During an Audit

Another sign of an ownership problem appears when an auditor asks Production a question—and everyone immediately looks at the Quality Manager.

A mature QMS isn't demonstrated by how well Quality can answer every question.

It's demonstrated by how naturally employees can explain and perform their own activities.

When the auditor asks about Purchasing, Purchasing should answer. When the question concerns Production, Production should explain the process.

Quality can coordinate, clarify requirements and help locate evidence—but it shouldn't become a human shield between the auditor and the organization.

Training Completion Isn't the Same as Competence

A dashboard showing 100% training completion looks reassuring.

But what does an electronic acknowledgement actually prove?

It proves that someone acknowledged the document—not necessarily that they understood the change or can perform the activity correctly.

Training methods should therefore be proportionate to the activity, its complexity and its risk. Depending on the situation, competence might require a discussion, scenario-based questions or practical demonstration rather than another signature.

Stop Creating Procedures for an Imaginary Company

Quality can also lose credibility by designing processes that the organization cannot realistically operate.

More signatures, approvals, meetings and forms don't automatically create a stronger QMS.

Patient safety, product performance and legal requirements are non-negotiable—but QA/RA professionals also need to distinguish between a genuine requirement and a preferred way of meeting that requirement.

An effective approach understands the regulatory objective and works with the organization to find a practical, proportionate and defensible way to achieve it.

From Quality Police to Quality Influencer

Management doesn't make decisions using regulatory language alone.

Simply saying “Clause X requires us to do this” may be technically correct, but it doesn't always help decision-makers understand the impact.

An influential QA/RA professional translates regulatory concerns into consequences management can evaluate.

That means speaking several languages:

Regulation → Patient/User Risk → Operations → Finance → Management Decisions

Influence starts when people understand how a Quality concern affects the objective they're trying to achieve.

Bring Options, Not Only Obstacles

Management meetings are decision-making environments.

When possible, Quality should explain the problem, identify the non-negotiable regulatory or safety boundaries, and present possible paths forward.

Some situations allow different compliant approaches. Others don't: a legal obligation doesn't become optional because the project is late, and an unacceptable safety risk cannot simply be accepted because fixing it is expensive.

The role of QA/RA is to inform, warn and guide, while escalating appropriately when necessary.

Quality Is a Collective Responsibility

When one Quality professional becomes the author of every nonconformity, owner of every CAPA, coordinator of every audit, author of every procedure and reminder system for every overdue action, burnout becomes almost inevitable.

The solution isn't another time-management technique.

It's moving from individual dependency to collective ownership.

Quality should build the system, support the people operating it, challenge the evidence and monitor effectiveness. But the organization must own the activities that actually create product quality.

Final Takeaway

The goal of QA/RA isn't to win every argument, become the most feared department or keep every dashboard green.

The goal is to improve the quality of the organization's decisions.

Don't become the Quality Tyrant.

Don't disappear as the Invisible Quality Manager.

Become the Quality Influencer who connects regulatory expectations, patient safety and business reality.

Who is Monir El Azzouzi? 

Monir El Azzouzi is the founder and CEO of Easy Medical Device a Consulting firm that is supporting Medical Device manufacturers for any Quality and Regulatory affairs activities all over the world. Monir can help you to create your Quality Management System, Technical Documentation or he can also take care of your Clinical Evaluation, Clinical Investigation through his team or partners. Easy Medical Device can also become your Authorized Representative and Independent Importer Service provider for EU, UK and Switzerland. 

Monir has around 16 years of experience within the Medical Device industry working for small businesses and also big corporate companies. He has now supported around 100 clients to remain compliant on the market. His passion to the Medical Device filed pushed him to create educative contents like, blog, podcast, YouTube videos, LinkedIn Lives where he invites guests who are sharing educative information to his audience. Visit easymedicaldevice.com to know more.  If you need help implementing QMSR or preparing your teams for FDA inspections, contact: info@easymedicaldevice.com

 If you are located outside the EU/UK/Switzerland and need an Authorized Representative (and possibly an Importer), we can support you as well.

Social Media to follow

Monir El Azzouzi Linkedin: https://linkedin.com/in/melazzouzi

Twitter: https://twitter.com/elazzouzim

Pinterest: https://www.pinterest.com/easymedicaldevice

Instagram: https://www.instagram.com/easymedicaldevice

This podcast is hosted by Podcastics, the easiest platform to create and publish your podcast.

A company says its Medical Device Technical Documentation is 90% or 95% ready.

The Risk Management File exists. The Clinical Evaluation is complete. Testing has been performed. The GSPR checklist and IFU are available.

But there's an important question:

95% of what?

Having all the expected documents doesn't necessarily mean your Technical Documentation is ready for assessment. Like a puzzle, you can have every piece on the table—but if some pieces are outdated, others belong to a different version of the product, and several don't fit together, the puzzle isn't complete.

1. Start With the Product, Not Annex II

Instead of immediately opening an Annex II template and looking for documents to fill each section, start with a more fundamental question:

What exactly are we trying to certify?

Your intended purpose, patient population, intended users, use environment, indications, contraindications, lifetime, claims, variants and accessories should provide a common source of truth across the Technical Documentation.

If Marketing makes a claim that isn't reflected in the intended purpose, Clinical Evaluation or Risk Management File, you may already have a significant consistency problem.

2. Challenge Your Regulatory Assumptions

“It's Class IIa because our competitor is Class IIa” isn't a classification rationale.

Early assumptions about qualification, classification and conformity assessment can influence testing, clinical strategy, budget and Notified Body involvement.

Those assumptions should therefore be challenged and properly documented before they become expensive to change.

3. Use the GSPR to Build the Dossier

The GSPR shouldn't simply appear at the end of the project as another checklist.

For every applicable requirement, ask:

How will we demonstrate conformity?

That means identifying the relevant standard, specification, analysis, test or report—and determining whether the required evidence actually exists.

Used this way, the GSPR becomes a tool for building Technical Documentation and identifying evidence gaps early.

4. Available Doesn't Mean Adequate

One of the biggest mistakes in Technical Documentation gap assessments is asking only:

“Do we have this document?”

A better question is:

“Is this evidence adequate for the device we're certifying?”

A biocompatibility report may exist—but does it cover the same materials, manufacturing process, patient-contacting components and contact duration?

Software verification may exist—but does it cover the current software version?

Clinical evidence may exist—but does it support the current intended purpose and claims?

That's why Available, Applicable and Adequate are three different things.

5. Make Sure the Puzzle Fits

Before submission, consistency and traceability become critical.

Imagine the IFU says the device can be used for seven days, while the Risk Management File and biological evaluation assume only 24 hours.

Every document exists—but together they don't tell a coherent story.

A reviewer should be able to trace important claims through intended purpose, design requirements, verification, clinical evidence, risk management, labeling and PMS.

Likewise, important risks should connect logically to risk controls, design implementation, verification, residual risk and post-market monitoring.

The 80/20 Approach to Technical Documentation

Instead of focusing first on the number of documents completed, focus on five questions:

Do we understand the product and its claims?
Is our regulatory strategy defensible?
Have requirements been translated into evidence needs?
Is our evidence adequate?
Does everything tell the same story?

Strong foundations make the rest of Technical Documentation much easier to structure.

EMD Technical Documentation Roadmap

To support this process, Easy Medical Device created the EMD Technical Documentation Roadmap.

The tool provides a structure for understanding the product, documenting regulatory strategy, mapping requirements, identifying standards and guidance, connecting risks with evidence, assessing gaps, assigning responsibilities, performing consistency checks, and ultimately mapping the documentation into Annex II and Annex III.

Final Takeaway

Stop thinking about Technical Documentation as a collection of folders that need to be filled.

Think about what the reviewer needs to understand:

Is there sufficient, coherent evidence demonstrating that this device conforms with the applicable requirements?

Your Technical Documentation isn't a filing cabinet.

Easy Medical Device Services

CE Marking • MDR • IVDR • Technical Documentation

Medical Device Market Access Services – Easy Medical Device

Back Office Services (BOSS Program)

SmartEye eQMS

SmartEye – eQMS – Easy Medical Device

EasyIFU

Electronic IFU & Label Creation

EasyIFU – Easy Medical Device

Authorized Representative

EU • UK • Switzerland

Worldwide Market Access

Market Access

Market Access

https://easymedicaldevice.com/services/market-access/embed/#?secret=qJuMYs1tqH#?secret=dFwrzZJcuH

Social Media to follow

Monir El Azzouzi Linkedin: https://linkedin.com/in/melazzouzi

Twitter: https://twitter.com/elazzouzim

Pinterest: https://www.pinterest.com/easymedicaldevice

Instagram: https://www.instagram.com/easymedicaldevice

This podcast is hosted by Podcastics, the easiest platform to create and publish your podcast.

Medical device regulation continues to evolve across multiple markets. For manufacturers, the challenge isn't simply following every new publication—it's understanding which developments require action, which ones need monitoring, and how they affect existing regulatory strategies.

This latest Medical Device Made Easy regulatory update reviews selected developments from July and August 2026 across Europe, Switzerland, the UK, United States, India, Singapore, and Brazil.

🇪🇺 UDI Assignment Under Distributor Branding

Read MDCG 2026-5 – UDI Assignment

MDCG 2026-5 addresses situations where the same medical device is sold under both the manufacturer's brand and a distributor's brand.

Different UDI-DIs may be appropriate, but when the original manufacturer remains the legal manufacturer, the codes must remain assigned by and linked to that manufacturer. This makes existing private-label arrangements, UDI structures, EUDAMED records, and agreements worth reviewing.

🇪🇺 Notified Body Certification & Fee Transparency

Team-NB MDR Certification Process v2.1

European Commission Notified Body Fee Directory

Team-NB's updated consensus paper maps the MDR certification journey from pre-application and quotation through conformity assessment, certification, and surveillance.

Combined with the European Commission's consolidated directory of Notified Body fee pages, these resources can help manufacturers better understand both the certification process and the costs that need to be considered when planning market access.

🇨🇭 swissdamed Registration Becomes Mandatory

Swissmedic – swissdamed Registration Obligation

From 1 July 2026, manufacturers and authorised representatives must register relevant devices, systems, and procedure packs in the swissdamed UDI Devices module.

The general transition period ends on 31 December 2026, making data preparation, responsibility allocation, and reconciliation important operational priorities for companies active in Switzerland.

🇬🇧 MHRA Guidance on Ambient Voice Technology

Read the MHRA Guidance

The MHRA provides useful clarification on when ambient voice technologies, including clinical scribes, may fall within medical device regulation.

Pure transcription or clinician-reviewed administrative summaries may remain outside medical device qualification, while diagnostic insights, treatment recommendations, or medical-performance claims can create a medical intended purpose.

🇺🇸 FDA FY 2027 Medical Device User Fees

FDA FY 2027 Medical Device User Fees

FDA published its FY 2027 medical device user fee notice, covering submission fees, establishment registration, small-business reductions, and related payment procedures.

The new fee year applies from 1 October 2026 through 30 September 2027, making the actual submission receipt date an important consideration when planning budgets.

🇮🇳 CDSCO Medical Device Software Guidance

Read the CDSCO Medical Device Software Guidance

India's CDSCO guidance covers qualification, classification, QMS, technical documentation, clinical evidence, AI-enabled software, cybersecurity, lifecycle change control, and post-market monitoring.

One important message for global manufacturers is that an EU or US classification rationale shouldn't simply be reused without mapping the device and evidence to the Indian framework.

🇸🇬 Singapore Updates Medical Device Cybersecurity Guidance

Singapore HSA Medical Device Guidance

Singapore HSA published an updated Best Practices Guide on Medical Device Cybersecurity in August 2026.

For connected medical devices and software manufacturers, it provides another useful benchmark for secure development, vulnerability management, updates, and post-market cybersecurity activities.

📅 Stay Updated on MedTech Events

Explore MedTech Conferences & Events on MedTechConf

The episode also highlights upcoming opportunities covering Article 117, MDR/IVDR, biocompatibility, AI, clinical evidence, PMS, vigilance, digital health, and African medical device regulation.

🎙️ Continue Learning with Easy Medical Device

Explore the Easy Medical Device Podcast

The July and August catalogue covers audit readiness, FDA clearance, risk management, QMS effectiveness, Intended Use, Master UDI-DI, Verification & Validation, DHF remediation, and global market access.

Easy Medical Device Services

CE Marking • MDR • IVDR • Technical Documentation

Medical Device Market Access Services – Easy Medical Device

Back Office Services (BOSS Program)

SmartEye eQMS

SmartEye – eQMS – Easy Medical Device

EasyIFU

Electronic IFU & Label Creation

EasyIFU – Easy Medical Device

Authorized Representative

EU • UK • Switzerland

Worldwide Market Access

Market Access

https://easymedicaldevice.com/services/market-access/embed/#?secret=LwbhU8XuNP#?secret=MqJ5tTiYnQ

Social Media to follow

Monir El Azzouzi Linkedin: https://linkedin.com/in/melazzouzi

Twitter: https://twitter.com/elazzouzim

Pinterest: https://www.pinterest.com/easymedicaldevice

Instagram: https://www.instagram.com/easymedicaldevice

This podcast is hosted by Podcastics, the easiest platform to create and publish your podcast.

Developing a medical device successfully requires several pieces to work together. Manufacturers must demonstrate that the product meets its requirements, maintain reliable design documentation, and understand how regulatory expectations differ—or increasingly align—across global markets.

In this Easy Medical Device podcast collection, we explore three connected topics that represent different stages of this journey: Verification & Validation, Design History File remediation, and IMDRF and regulatory reliance.

Making Verification & Validation Practical

Verification and Validation are fundamental parts of medical device development, but the distinction between them can sometimes create confusion.

Verification focuses on whether the device has been developed according to defined requirements, while validation considers whether the resulting device meets its intended use and user needs.

Understanding how to plan and execute V&V effectively helps manufacturers build stronger evidence around device performance and supports a more structured development process.

When Your Design History File Needs Remediation

What happens when the product has already been developed, but the Design History File doesn't properly demonstrate the development journey?

DHF remediation can become necessary when documentation is incomplete, fragmented, poorly traceable, or does not adequately demonstrate how design controls were applied.

The discussion explores the importance of rebuilding those connections and creating documentation that clearly demonstrates the relationship between requirements, design activities, V&V evidence, risk management, and design decisions.

The objective isn't simply to create more documentation. It's to create a coherent and traceable design history.

IMDRF, Regulatory Reliance and Global Market Access

Once a device is ready for market, manufacturers face another challenge: navigating multiple regulatory systems around the world.

The International Medical Device Regulators Forum (IMDRF) plays an important role in encouraging greater regulatory convergence internationally.

Regulatory reliance takes this concept further by allowing authorities, where applicable, to leverage assessments or decisions from other trusted regulatory authorities rather than unnecessarily duplicating the entire review process.

For manufacturers seeking international expansion, understanding these developments can become an important part of building an efficient global market access strategy.

Connecting the Entire Journey

These three topics may appear separate, but they represent a logical progression:

Verification & Validation → Design Documentation → Global Regulatory Approvals

First, manufacturers need evidence that the device performs as expected.

Then, they need documentation that clearly demonstrates how the device was developed and controlled.

Finally, they need a regulatory strategy capable of bringing that device into different markets.

For MedTech companies, getting these elements right can create a stronger foundation for compliance, regulatory submissions, and international market access.

A successful regulatory journey doesn't begin with the submission—it begins with how the device is designed, tested, documented, and prepared for the markets it intends to enter.

Who is Monir El Azzouzi? 

Monir El Azzouzi is the founder and CEO of Easy Medical Device a Consulting firm that is supporting Medical Device manufacturers for any Quality and Regulatory affairs activities all over the world. Monir can help you to create your Quality Management System, Technical Documentation or he can also take care of your Clinical Evaluation, Clinical Investigation through his team or partners. Easy Medical Device can also become your Authorized Representative and Independent Importer Service provider for EU, UK and Switzerland. 

Monir has around 16 years of experience within the Medical Device industry working for small businesses and also big corporate companies. He has now supported around 100 clients to remain compliant on the market. His passion to the Medical Device filed pushed him to create educative contents like, blog, podcast, YouTube videos, LinkedIn Lives where he invites guests who are sharing educative information to his audience. Visit easymedicaldevice.com to know more.  If you need help implementing QMSR or preparing your teams for FDA inspections, contact: info@easymedicaldevice.com

 If you are located outside the EU/UK/Switzerland and need an Authorized Representative (and possibly an Importer), we can support you as well.

Social Media to follow

Monir El Azzouzi Linkedin: https://linkedin.com/in/melazzouzi

Twitter: https://twitter.com/elazzouzim

Pinterest: https://www.pinterest.com/easymedicaldevice

Instagram: https://www.instagram.com/easymedicaldevice

This podcast is hosted by Podcastics, the easiest platform to create and publish your podcast.

Bringing a medical device to market requires more than achieving regulatory approval. The decisions made early in product development can influence classification, clinical evidence, risk management, labeling, identification, and ultimately the entire market access strategy.

In this Easy Medical Device podcast collection, we focus on two important regulatory topics: defining a proper Intended Use and understanding Master UDI-DI.

Intended Use: The Foundation of Your Regulatory Strategy

Intended Use may look like a simple statement, but it can influence almost every part of a medical device's regulatory pathway.

A poorly defined Intended Use can create downstream problems with device classification, clinical evaluation, risk management, and regulatory submissions.

Even small changes in wording can have significant consequences, particularly for areas such as Software as a Medical Device (SaMD).

The discussion also explores a common misconception: manufacturers cannot simply use a disclaimer or change their labeling to avoid medical device regulation when the actual intended purpose and claims bring the product within the medical device framework.

Understanding Master UDI-DI

Device identification is another increasingly important part of regulatory strategy.

Master UDI-DI introduces an additional layer that MedTech manufacturers need to understand when managing device identification and regulatory information.

Understanding how it fits into the broader UDI framework can help manufacturers prepare their documentation and data strategy while avoiding mistakes that could create additional regulatory or operational work later.

Building a Stronger Market Access Strategy

Although Intended Use and Master UDI-DI address different regulatory challenges, they share an important principle: regulatory strategy should be considered early rather than treated as an administrative task at the end of development.

Clearly defining your device, understanding its regulatory implications, and preparing the right identification strategy can help create a more predictable path toward market access.

For Regulatory Affairs professionals and medical device manufacturers, these conversations provide practical insights into two topics that can significantly influence the regulatory journey from product development to market.

Who is Monir El Azzouzi? 

Monir El Azzouzi is the founder and CEO of Easy Medical Device a Consulting firm that is supporting Medical Device manufacturers for any Quality and Regulatory affairs activities all over the world. Monir can help you to create your Quality Management System, Technical Documentation or he can also take care of your Clinical Evaluation, Clinical Investigation through his team or partners. Easy Medical Device can also become your Authorized Representative and Independent Importer Service provider for EU, UK and Switzerland. 

Monir has around 16 years of experience within the Medical Device industry working for small businesses and also big corporate companies. He has now supported around 100 clients to remain compliant on the market. His passion to the Medical Device filed pushed him to create educative contents like, blog, podcast, YouTube videos, LinkedIn Lives where he invites guests who are sharing educative information to his audience. Visit easymedicaldevice.com to know more.  If you need help implementing QMSR or preparing your teams for FDA inspections, contact: info@easymedicaldevice.com

 If you are located outside the EU/UK/Switzerland and need an Authorized Representative (and possibly an Importer), we can support you as well.

Social Media to follow

Monir El Azzouzi Linkedin: https://linkedin.com/in/melazzouzi

Twitter: https://twitter.com/elazzouzim

Pinterest: https://www.pinterest.com/easymedicaldevice

Instagram: https://www.instagram.com/easymedicaldevice

This podcast is hosted by Podcastics, the easiest platform to create and publish your podcast.

Having an ISO 13485 Quality Management System in place does not automatically mean that your quality processes are effective.

A strong QMS should help an organization identify problems, evaluate their significance, capture information from the market, investigate systemic issues, and continuously improve.

In this Easy Medical Device podcast collection, we examine several situations that can reveal whether a QMS is truly functioning—or simply looks good on paper.

Understanding NC vs CAPA

One of the most misunderstood areas of quality management is determining when to open a Nonconformity and when to escalate an issue into a CAPA.

Not every isolated problem requires a complete CAPA investigation. However, when an issue becomes recurring, systemic, significant, or potentially high-risk, a deeper investigation may be necessary.

The objective isn't to create as many CAPAs as possible. It's to recognize the problems that genuinely require root cause investigation and corrective action.

Why “We've Never Had a Complaint” Can Be Dangerous

Zero complaints may sound like excellent news, but it can also raise an important question:

Is your organization effectively capturing all sources of customer and post-market feedback?

Potential complaints may appear through distributor communications, service reports, customer emails, returned products, training feedback, or other customer-facing channels.

If this information isn't properly evaluated, the organization may miss important product performance or safety signals.

The Fake QMS Problem

A Quality Management System can look excellent on paper.

Procedures exist. Forms are available. CAPA processes are defined. Risk management documentation is complete.

But if employees don't follow those processes in daily operations, the QMS can become disconnected from reality.

That's the core of the “fake QMS” problem: the documented system and the way the company actually operates become two different systems.

During an audit, this gap can quickly become visible.

Building a QMS That Actually Works

An effective QMS should be integrated into everyday operations rather than maintained only for certification or audits.

Problems should be identified and evaluated appropriately. Customer feedback should feed into complaint handling and post-market activities. Significant and recurring issues should trigger investigation, and lessons learned should contribute to continuous improvement.

Ultimately, the goal isn't to create a perfect-looking Quality Management System.

The goal is to create a QMS that helps your organization consistently identify problems, manage risk, improve processes, and support the delivery of safe and effective medical devices.

Who is Monir El Azzouzi? 

Monir El Azzouzi is the founder and CEO of Easy Medical Device a Consulting firm that is supporting Medical Device manufacturers for any Quality and Regulatory affairs activities all over the world. Monir can help you to create your Quality Management System, Technical Documentation or he can also take care of your Clinical Evaluation, Clinical Investigation through his team or partners. Easy Medical Device can also become your Authorized Representative and Independent Importer Service provider for EU, UK and Switzerland. 

Monir has around 16 years of experience within the Medical Device industry working for small businesses and also big corporate companies. He has now supported around 100 clients to remain compliant on the market. His passion to the Medical Device filed pushed him to create educative contents like, blog, podcast, YouTube videos, LinkedIn Lives where he invites guests who are sharing educative information to his audience. Visit easymedicaldevice.com to know more.  If you need help implementing QMSR or preparing your teams for FDA inspections, contact: info@easymedicaldevice.com

 If you are located outside the EU/UK/Switzerland and need an Authorized Representative (and possibly an Importer), we can support you as well.

Social Media to follow

Monir El Azzouzi Linkedin: https://linkedin.com/in/melazzouzi

Twitter: https://twitter.com/elazzouzim

Pinterest: https://www.pinterest.com/easymedicaldevice

Instagram: https://www.instagram.com/easymedicaldevice

This podcast is hosted by Podcastics, the easiest platform to create and publish your podcast.

Quality and regulatory compliance are fundamental to bringing safe and effective medical devices to market. As regulations continue to evolve and technologies become more complex, manufacturers must adopt a proactive approach to quality throughout the entire product lifecycle.

This podcast collection explores key topics shaping today's medical device industry, including the FDA's transition to the Quality Management System Regulation (QMSR), effective validation and supplier management strategies, and structured approaches to managing software defects in Software as a Medical Device (SaMD).

Together, these discussions highlight how strong quality systems extend beyond documentation. They emphasize the importance of risk-based thinking, supplier oversight, software quality, and continuous improvement to ensure compliance while protecting patients.

Whether you're working in Quality Assurance, Regulatory Affairs, Engineering, or Product Development, these conversations offer practical insights to help strengthen your Quality Management System and prepare for the evolving regulatory landscape.

Who is Monir El Azzouzi? 

Monir El Azzouzi is the founder and CEO of Easy Medical Device a Consulting firm that is supporting Medical Device manufacturers for any Quality and Regulatory affairs activities all over the world. Monir can help you to create your Quality Management System, Technical Documentation or he can also take care of your Clinical Evaluation, Clinical Investigation through his team or partners. Easy Medical Device can also become your Authorized Representative and Independent Importer Service provider for EU, UK and Switzerland. 

Monir has around 16 years of experience within the Medical Device industry working for small businesses and also big corporate companies. He has now supported around 100 clients to remain compliant on the market. His passion to the Medical Device filed pushed him to create educative contents like, blog, podcast, YouTube videos, LinkedIn Lives where he invites guests who are sharing educative information to his audience. Visit easymedicaldevice.com to know more.  If you need help implementing QMSR or preparing your teams for FDA inspections, contact: info@easymedicaldevice.com

 If you are located outside the EU/UK/Switzerland and need an Authorized Representative (and possibly an Importer), we can support you as well.

Social Media to follow

Monir El Azzouzi Linkedin: https://linkedin.com/in/melazzouzi

Twitter: https://twitter.com/elazzouzim

Pinterest: https://www.pinterest.com/easymedicaldevice

Instagram: https://www.instagram.com/easymedicaldevice

This podcast is hosted by Podcastics, the easiest platform to create and publish your podcast.

What would happen if your Risk Management File disappeared tomorrow?

Would your medical device suddenly become less safe?

For many organizations, the answer is probably no—because the file was created to document decisions after they were made, rather than guiding those decisions in the first place.

In this episode of the Medical Device Made Easy Podcast, we challenge the traditional view of risk management and explore why ISO 14971 should be treated as a continuous decision-making framework—not simply a regulatory requirement.

What You'll Learn

Is Your Risk Management File Driving Design?

Risk management should begin at the earliest stages of product development.

Instead of documenting completed work, it should actively influence design choices, identify hazards, evaluate risks, and verify that risk control measures are effective throughout development.

Common Signs Your Risk File Is Becoming Fiction

Many organizations unintentionally weaken their risk management process by:

Reusing generic hazard lists from previous projects

Completing risk documentation just before certification

Failing to connect hazards with design decisions

Treating the Risk Management File as a static document instead of a living process

Risk Management Is a Cross-Functional Responsibility

Effective risk management isn't owned solely by Quality or Regulatory Affairs.

Engineering, Clinical Affairs, Manufacturing, Service, Post-Market Surveillance, and Customer Support all generate valuable information that should continuously improve the organization's understanding of product risk.

Why Traceability Matters

Strong traceability allows organizations to answer critical questions:

Why was this hazard identified?

Which design decision addressed it?

How was the risk control verified?

Does new PMS or complaint data change our understanding of the risk?

Would we make the same decision today?

When these connections are visible, risk management becomes a practical engineering tool rather than a compliance exercise.

Keeping Your Risk Management File Alive

Certification is not the end of risk management.

Complaints, vigilance reports, supplier changes, software updates, PMCF findings, literature reviews, and post-market surveillance all provide new information that should feed back into your risk assessment.

Organizations that continuously update their Risk Management File are better equipped to identify emerging risks, improve product safety, and support long-term regulatory compliance.

Key Takeaway

A Risk Management File should never exist simply to satisfy auditors or Notified Bodies.

Its real purpose is to demonstrate how risk-based thinking influences every important design decision throughout the product lifecycle.

The strongest organizations don't maintain a perfect document.

They maintain a living risk management process—one that evolves as new knowledge is gained and continuously helps make medical devices safer for patients.

Social Media to follow

Monir El Azzouzi Linkedin: https://linkedin.com/in/melazzouzi

Twitter: https://twitter.com/elazzouzim

Pinterest: https://www.pinterest.com/easymedicaldevice

Instagram: https://www.instagram.com/easymedicaldevice

This podcast is hosted by Podcastics, the easiest platform to create and publish your podcast.

Many medical device startups assume they're audit ready because they have documented procedures, completed templates, and a Quality Management System in place.

However, successful audits require much more than organized documentation.

In this episode of the Medical Device Made Easy Podcast, we welcome Chiratana Pot from Enlil to discuss what true audit readiness looks like and why continuous compliance is far more effective than preparing only when an audit is scheduled.

What You'll Learn

What Is an Audit Really?

Many organizations view audits as exercises designed to uncover mistakes.

In reality, audits evaluate whether your Quality Management System is implemented effectively and consistently—not simply whether procedures exist.

Compliance vs. Audit Readiness

Being compliant and being audit ready are not always the same.

The discussion explores how companies can move beyond documentation and demonstrate that their processes are actively followed throughout the organization.

Common Startup Mistakes

Drawing from experience working with MedTech startups, Chiratana shares the most frequent challenges organizations encounter before their first audit, including assumptions that often lead to unexpected findings.

Why Traceability Matters

One of the central themes of the episode is traceability.

We examine how effective traceability connects requirements, risks, design decisions, verification activities, and documentation—making change management more efficient and strengthening overall compliance.

How Enlil Supports Connected Development

The conversation concludes with an overview of Enlil's approach to connected development, explaining why integrating quality into product development from the beginning helps organizations maintain continuous audit readiness rather than relying on last-minute preparation.

Key Takeaway

Audit readiness is not a checklist completed before an inspection.

It's the result of building a culture where quality, traceability, and compliance are embedded into everyday work.

For MedTech startups, developing this mindset early can simplify audits, improve product quality, and create a stronger foundation for long-term regulatory success.

Who is Monir El Azzouzi? 

Monir El Azzouzi is the founder and CEO of Easy Medical Device a Consulting firm that is supporting Medical Device manufacturers for any Quality and Regulatory affairs activities all over the world. Monir can help you to create your Quality Management System, Technical Documentation or he can also take care of your Clinical Evaluation, Clinical Investigation through his team or partners. Easy Medical Device can also become your Authorized Representative and Independent Importer Service provider for EU, UK and Switzerland. 

Monir has around 16 years of experience within the Medical Device industry working for small businesses and also big corporate companies. He has now supported around 100 clients to remain compliant on the market. His passion to the Medical Device filed pushed him to create educative contents like, blog, podcast, YouTube videos, LinkedIn Lives where he invites guests who are sharing educative information to his audience. Visit easymedicaldevice.com to know more.  If you need help implementing QMSR or preparing your teams for FDA inspections, contact: info@easymedicaldevice.com

 If you are located outside the EU/UK/Switzerland and need an Authorized Representative (and possibly an Importer), we can support you as well.

Who is Chiratana (CP) Pot?

Chiratana (CP) Pot is Senior Director of Product at Enlil, a cloud-native, AI-driven development traceability platform built for medical device and life sciences organizations. Enlil connects quality, regulatory, R&D, manufacturing, and operations teams through a unified system of record, enabling traceability, auditability, and regulatory readiness across the product lifecycle. CP works with MedTech organizations to strengthen design controls and audit readiness. He is a frequent contributor on topics including design controls, lifecycle traceability, and regulatory readiness, helping organizations move beyond documentation compliance to evidence-based product development.

Link

Chiratana's linkedin: https://www.linkedin.com/in/chiratana-pot/

Website: https://enlil.com/

Enlil’s LinkedIn: https://www.linkedin.com/company/enlil-inc/

Social Media to follow

Monir El Azzouzi Linkedin: https://linkedin.com/in/melazzouzi

Twitter: https://twitter.com/elazzouzim

Pinterest: https://www.pinterest.com/easymedicaldevice

Instagram: https://www.instagram.com/easymedicaldevice

This podcast is hosted by Podcastics, the easiest platform to create and publish your podcast.

For many medical device startups, obtaining FDA clearance seems like a clear, linear process.

Identify a predicate device.

Prepare your documentation.

Submit your application.

Wait for clearance.

In reality, the journey is rarely that simple.

In this episode of the Medical Device Made Easy Podcast, Joanna Nathan, CEO of Prana Surgical, shares her firsthand experience navigating the FDA clearance process and discusses the challenges that many startups only discover after they begin.

Topics Covered

The Reality Behind FDA Clearance

When do founders realize the process is more complex than expected?

What would they do differently if they could start again?

Predicate Devices and Substantial Equivalence

Choosing the right predicate device is one of the most important strategic decisions in a 510(k) submission.

We discuss:

Predicate device selection

Intended use considerations

Technological characteristics

Common misconceptions about substantial equivalence

Building a Product with the FDA in Mind

The conversation explores how early regulatory decisions influence:

Product development

Testing strategy

Documentation

Risk management

Manufacturing planning

Working with the FDA

How valuable are Pre-Submission (Q-Sub) meetings?

What questions should manufacturers ask?

What mistakes should they avoid before engaging with the FDA?

Lessons Every Startup Should Know

Joanna shares practical advice on:

Unexpected FDA questions

Common causes of delays

Software validation

Biocompatibility

Usability studies

Documentation preparation

The biggest misconceptions surrounding FDA clearance

Key Takeaway

FDA clearance is much more than completing regulatory paperwork.

Successful companies integrate regulatory thinking into product development from the very beginning.

Making the right strategic decisions early can save significant time, reduce costs, and improve the likelihood of a successful FDA submission.

Whether you're launching your first medical device or preparing your next regulatory submission, this episode provides practical insights to help you navigate the FDA clearance journey with greater confidence.

Who is Monir El Azzouzi? 

Monir El Azzouzi is the founder and CEO of Easy Medical Device a Consulting firm that is supporting Medical Device manufacturers for any Quality and Regulatory affairs activities all over the world. Monir can help you to create your Quality Management System, Technical Documentation or he can also take care of your Clinical Evaluation, Clinical Investigation through his team or partners. Easy Medical Device can also become your Authorized Representative and Independent Importer Service provider for EU, UK and Switzerland. 

Monir has around 16 years of experience within the Medical Device industry working for small businesses and also big corporate companies. He has now supported around 100 clients to remain compliant on the market. His passion to the Medical Device filed pushed him to create educative contents like, blog, podcast, YouTube videos, LinkedIn Lives where he invites guests who are sharing educative information to his audience. Visit easymedicaldevice.com to know more.  If you need help implementing QMSR or preparing your teams for FDA inspections, contact: info@easymedicaldevice.com

 If you are located outside the EU/UK/Switzerland and need an Authorized Representative (and possibly an Importer), we can support you as well.

Link

Joanna’s LinkedIn: https://www.linkedin.com/in/joannacnathan

Prana System: https://www.pranasurgical.com/prana-system

Prana Surgical’s LinkedIn: https://www.linkedin.com/company/pranasurgical

Social Media to follow

Monir El Azzouzi Linkedin: https://linkedin.com/in/melazzouzi

Twitter: https://twitter.com/elazzouzim

Pinterest: https://www.pinterest.com/easymedicaldevice

Instagram: https://www.instagram.com/easymedicaldevice

This podcast is hosted by Podcastics, the easiest platform to create and publish your podcast.

For many medical device companies, a successful audit is seen as the ultimate proof that their Quality Management System is performing well.

Few or no findings.

Positive feedback from auditors.

Management celebrates.

But does passing an audit really mean your QMS is healthy?

In this episode of the Medical Device Made Easy Podcast, we explore why the answer is often no.

Audits Are Samples—Not Complete Evaluations

Whether it's an ISO 13485 audit, a Notified Body assessment, an FDA inspection, or an internal audit, auditors can only review a small sample of your quality system.

They cannot examine every complaint, every supplier, every design decision, or every production batch.

A successful audit demonstrates compliance with the sampled evidence—but it does not guarantee that every aspect of the system is functioning effectively.

The "Audit Mode" Problem

Many organizations unintentionally enter "Audit Mode" before inspections.

Training records are updated.

CAPAs are closed.

Procedures are revised.

Management reviews suddenly take place.

While preparation is important, organizations should ask themselves:

Are we improving our QMS—or simply preparing for an audit?

Culture Matters More Than Findings

Some of the most significant quality risks rarely appear during an audit.

Examples include:

Employees afraid to report mistakes

Poor communication between departments

Weak supplier relationships

Design decisions that are never challenged

Informal workarounds that bypass documented procedures

These issues can remain invisible during a short audit while gradually increasing organizational risk.

Measuring the Real Health of Your QMS

Instead of focusing only on audit findings, management should monitor indicators such as:

Complaint investigation timelines

CAPA closure performance

Supplier management effectiveness

Risk management updates

Cross-functional communication

Near-miss reporting

Continuous improvement initiatives

These metrics often provide a far more accurate picture of QMS maturity than the number of audit findings alone.

Final Thought

Passing an audit is an important achievement and deserves recognition.

However, organizations should never confuse regulatory compliance with operational excellence.

A healthy Quality Management System is not built to impress auditors.

It is built to consistently deliver safe, effective, and compliant medical devices while continuously improving every day—even when no auditor is watching.

Who is Monir El Azzouzi? 

Monir El Azzouzi is the founder and CEO of Easy Medical Device a Consulting firm that is supporting Medical Device manufacturers for any Quality and Regulatory affairs activities all over the world. Monir can help you to create your Quality Management System, Technical Documentation or he can also take care of your Clinical Evaluation, Clinical Investigation through his team or partners. Easy Medical Device can also become your Authorized Representative and Independent Importer Service provider for EU, UK and Switzerland. 

Monir has around 16 years of experience within the Medical Device industry working for small businesses and also big corporate companies. He has now supported around 100 clients to remain compliant on the market. His passion to the Medical Device filed pushed him to create educative contents like, blog, podcast, YouTube videos, LinkedIn Lives where he invites guests who are sharing educative information to his audience. Visit easymedicaldevice.com to know more.  If you need help implementing QMSR or preparing your teams for FDA inspections, contact: info@easymedicaldevice.com

 If you are located outside the EU/UK/Switzerland and need an Authorized Representative (and possibly an Importer), we can support you as well.

Social Media to follow

Monir El Azzouzi Linkedin: https://linkedin.com/in/melazzouzi

Twitter: https://twitter.com/elazzouzim

Pinterest: https://www.pinterest.com/easymedicaldevice

Instagram: https://www.instagram.com/easymedicaldevice

This podcast is hosted by Podcastics, the easiest platform to create and publish your podcast.

Sponsor

Medboard: https://www.medboard.com/

Europe

Well-Established Technologies - Publication of the Delegated act: https://ec.europa.eu/newsroom/sante/newsletter-archives/77013

2 Delegated acts:

Class III and implantables: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=OJ:L_202601451

Class Iib implantables: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=OJ:L_202601359

In line with the Administrative Simplification Agenda

COMBINE Phase 2 - Increase of Scope : https://ec.europa.eu/newsroom/sante/newsletter-archives/76937

Incease of Scope:

Eligibility for multinational investigational medicinal product (IMP) clinical trials combined with:

Performance studies of IVDs or companion diagnostics requiring authorisation

Clinical investigations of medical devices requiring authorisation

Combined studies with Advanced Therapy Medicinal Products (ATMPs) possible

Options for single or separate sponsors

Procedure for substantial modifications in combined studies authorised in the pilot to be launched later in phase 2

Exploration of single protocols and joint documents

Austria: FSC deficiencies - Most issues identified: https://www.basg.gv.at/en/companies/medical-devices/certificate-of-free-sale/common-deficiencies

SSCP, Upload you should! - MDCG 2026-4 released: https://health.ec.europa.eu/document/download/a80332cf-e9f0-4d45-8863-3d96e8c2a675_en?filename=mdcg_2026-4_en.pdf

Start Date October 2026, Due date February 2027

Harmonized Standard update - A full list was disclosed: https://eur-lex.europa.eu/eli/dec_impl/2026/1231/oj

MDCG 2021-5 Rev 1 EU REP Symbol -Should you continue to use EC REP?   https://health.ec.europa.eu/document/download/e10f7694-67b4-4093-a969-6f7e43747c44_en?filename=md_mdcg_2021_5_appendix_en.pdf

During the transition time, within a staggered approach for the implementation, it is acceptable to use one or both symbols ‘EC REP’ and ‘EU REP’ on different levels of packaging, as well 

Team-NB- Micro Small Entreprise - Discount imposed  https://www.team-nb.org/wp-content/uploads/2026/06/Team-NB-PositionPaper-Micro-Small-Entreprise-Initiatives-V1-20260616.pdf

UK

Update of UK Borderline Guide - Remove of antimicrobial substances as Medical Devices: https://www.gov.uk/government/publications/borderlines-with-medical-devices

The line: 'Alcohol-only pre-injection swabs and wipes are considered to be medical devices as are those containing anti-microbial substances such as chlorhexidine, cetrimide or iodine.' 

has been changed to this: 

Alcohol-only pre-injection swabs and wipes are considered to be medical devices.

Switzerland

Swissdamed: Registration

New option: M2M and Master UDI-DI: https://www.swissmedic.ch/swissmedic/en/home/medical-devices/medizinprodukte-datenbank/swissdamed-informationen/neu-online-editor-m2m-produktregistierung-master-udi.html
Swissdamed UDI User guide: https://www.swissmedic.ch/dam/swissmedic/en/dokumente/medizinprodukte/mep_urr/bw630_40_841e_hb_swissdamed_user_guide_udi_devices_module.pdf.download.pdf/BW630_40_841e_HB_swissdamed_User_Guide_UDI_Devices_Module.pdf

Medtech Conf: Medtechconf.com

Podcast

Episode 393 - Best of „AI CE marking“: https://podcast.easymedicaldevice.com/393-2/
Episode 394 - NC vs CAPA: Are You Opening the Wrong Records?: https://podcast.easymedicaldevice.com/394-2/

Episode 395 - “We’ve Never Had a Complaint” — The Most Dangerous Sentence in Medical Devices: https://podcast.easymedicaldevice.com/395-2/

Easy Medical Device

Consulting activities (CE marking, Clinical Evaluation, QMS creation…) https://easymedicaldevice.com/services/mdr-ivdr-technical-documentation/

BOSS Program: Back Office Services

eQMS: https://easymedicaldevice.com/smarteye-eqms/

EasyIFU: eIFU and Label creation: https://easymedicaldevice.com/easyifu/

Authorized Representative in EU, UK and Switzerland

Market access all over the world: https://easymedicaldevice.com/services/market-access/

Social Media to follow

Monir El Azzouzi Linkedin: https://linkedin.com/in/melazzouzi

Twitter: https://twitter.com/elazzouzim

Pinterest: https://www.pinterest.com/easymedicaldevice

Instagram: https://www.instagram.com/easymedicaldevice

This podcast is hosted by Podcastics, the easiest platform to create and publish your podcast.

At first glance, hearing "We've never had a complaint" sounds like excellent news.

No customer dissatisfaction.
No product issues.
No safety concerns.

But for Quality and Regulatory professionals, this statement should trigger an entirely different question:

How do you know?

What Is a Complaint?

Many organizations believe a complaint only exists when a customer submits an official complaint form or explicitly uses the word "complaint."

Regulators take a much broader view.

A complaint may include:

Unexpected device performance

Product malfunctions

Customer dissatisfaction

Usability issues

Distributor observations

Technical support interactions

Returned products

Any information suggesting the device may not meet requirements

Complaints Are Often Hidden

Potential complaint signals can be found in:

Customer emails

Distributor communications

Service reports

Sales team discussions

Training sessions

Social media comments

Technical support tickets

If these sources are ignored, valuable post-market information is lost.

Why Zero Complaints Can Be a Red Flag

Imagine a company with:

5,000 devices on the market

Products sold in 20 countries

Daily clinical use

And yet...

No complaints

No usability observations

No customer questions

No returned devices

Experienced auditors may not celebrate.

Instead, they may question whether the complaint handling process is effective enough to capture real-world information.

Complaint Handling Impacts the Entire Quality System

Weak complaint collection doesn't only affect one procedure.

It directly influences:

Clinical Evaluation Reports (CER)

Post-Market Surveillance (PMS)

PMCF activities

PSUR preparation

Benefit-Risk assessments

State-of-the-art reviews

If complaint data is incomplete, clinical evidence may also be incomplete.

Five Practical Recommendations

Define complaints broadly.

Review every customer-facing information source.

Create a structured complaint screening process.

Trend data regularly to identify recurring issues.

Periodically challenge your system by asking:

"Would an auditor agree that we've identified every potential complaint?"

Final Thought

The next time someone proudly says,

"We've never had a complaint,"

don't celebrate immediately.

Ask instead,

"How do we know?"

Because in medical devices, the absence of complaints is not always evidence that everything is working perfectly.

Sometimes, it's evidence that nobody is looking.

Who is Monir El Azzouzi? 

Monir El Azzouzi is the founder and CEO of Easy Medical Device a Consulting firm that is supporting Medical Device manufacturers for any Quality and Regulatory affairs activities all over the world. Monir can help you to create your Quality Management System, Technical Documentation or he can also take care of your Clinical Evaluation, Clinical Investigation through his team or partners. Easy Medical Device can also become your Authorized Representative and Independent Importer Service provider for EU, UK and Switzerland. 

Monir has around 16 years of experience within the Medical Device industry working for small businesses and also big corporate companies. He has now supported around 100 clients to remain compliant on the market. His passion to the Medical Device filed pushed him to create educative contents like, blog, podcast, YouTube videos, LinkedIn Lives where he invites guests who are sharing educative information to his audience. Visit easymedicaldevice.com to know more.  If you need help implementing QMSR or preparing your teams for FDA inspections, contact: info@easymedicaldevice.com

 If you are located outside the EU/UK/Switzerland and need an Authorized Representative (and possibly an Importer), we can support you as well.

Social Media to follow

Monir El Azzouzi Linkedin: https://linkedin.com/in/melazzouzi

Twitter: https://twitter.com/elazzouzim

Pinterest: https://www.pinterest.com/easymedicaldevice

Instagram: https://www.instagram.com/easymedicaldevice

This podcast is hosted by Podcastics, the easiest platform to create and publish your podcast.

One of the most common sources of confusion in medical device Quality Management Systems is knowing when to open a Nonconformity (NC) and when to initiate a Corrective and Preventive Action (CAPA).

Some organizations turn every issue into a CAPA, while others rarely open one at all. Both extremes can create challenges during audits and may indicate an immature quality system.

In this episode of the Medical Device Made Easy Podcast, we explain the fundamental differences between NCs and CAPAs and explore real-life situations to help quality professionals make better decisions.

A Nonconformity simply indicates that a requirement has not been met. A CAPA, however, is a structured process designed to investigate and eliminate the root cause of significant, recurring, or systemic issues.

Through multiple scenarios, we discuss:

When an isolated event should remain a simple NC.

How trends and recurring problems justify CAPAs.

Why a single event can trigger a CAPA when patient safety is involved.

Whether a CAPA always requires a Nonconformity first.

Alternative sources of CAPAs, including complaints, audits, PMS activities, PSUR reviews, PMCF activities, and management reviews.

How auditors evaluate the maturity of a CAPA system.

The three questions every quality professional should ask before deciding between an NC and a CAPA.

The objective is not to open more CAPAs, nor to avoid them. The objective is to open the right CAPAs, based on risk, recurrence, and impact.

Understanding this distinction is essential for building a robust and effective quality management system that supports compliance, patient safety, and continuous improvement.

Who is Monir El Azzouzi? 

Monir El Azzouzi is the founder and CEO of Easy Medical Device a Consulting firm that is supporting Medical Device manufacturers for any Quality and Regulatory affairs activities all over the world. Monir can help you to create your Quality Management System, Technical Documentation or he can also take care of your Clinical Evaluation, Clinical Investigation through his team or partners. Easy Medical Device can also become your Authorized Representative and Independent Importer Service provider for EU, UK and Switzerland. 

Monir has around 16 years of experience within the Medical Device industry working for small businesses and also big corporate companies. He has now supported around 100 clients to remain compliant on the market. His passion to the Medical Device filed pushed him to create educative contents like, blog, podcast, YouTube videos, LinkedIn Lives where he invites guests who are sharing educative information to his audience. Visit easymedicaldevice.com to know more.  If you need help implementing QMSR or preparing your teams for FDA inspections, contact: info@easymedicaldevice.com

 If you are located outside the EU/UK/Switzerland and need an Authorized Representative (and possibly an Importer), we can support you as well.

Social Media to follow

Monir El Azzouzi Linkedin: https://linkedin.com/in/melazzouzi

Twitter: https://twitter.com/elazzouzim

Pinterest: https://www.pinterest.com/easymedicaldevice

Instagram: https://www.instagram.com/easymedicaldevice

This podcast is hosted by Podcastics, the easiest platform to create and publish your podcast.

Artificial intelligence is transforming healthcare, but developing an AI medical device is only part of the challenge. Manufacturers must also navigate certification requirements and maintain safety and performance throughout the entire product lifecycle.

In two podcast episodes featuring Sandy Wright and Osman El-Koubani, we explore the journey from certifying LLM-driven medical devices to managing them after CE marking.

Certifying LLM-Driven Medical Devices

Large Language Models such as ChatGPT, Gemini, and Claude introduce new regulatory challenges. Unlike traditional software, these systems raise questions around predictability, validation, traceability, supplier management, and model updates.

Topics discussed include:

What defines an LLM-driven medical device

Clinical evaluation strategies

Demonstrating clinical benefit

Using commercial AI models

Supplier controls and external dependencies

Significant changes and model updates

Life After CE Marking

Obtaining CE certification is not the end of the journey.

AI medical devices require continuous monitoring once they reach the market.

Manufacturers must address:

Performance drift in real-world settings

Collection and analysis of real-world data

AI retraining and change management

Predetermined Change Control Plans (PCCPs)

Post-Market Surveillance (PMS)

Continuous safety and performance evaluation

AI Devices Require a Lifecycle Approach

AI systems are dynamic technologies. Success depends not only on achieving certification, but also on maintaining control over performance, updates, and clinical safety throughout the product lifecycle.

As regulations continue to evolve, manufacturers must combine robust development practices with proactive post-market monitoring to ensure long-term compliance and patient safety.

Who is Monir El Azzouzi? 

Monir El Azzouzi is the founder and CEO of Easy Medical Device a Consulting firm that is supporting Medical Device manufacturers for any Quality and Regulatory affairs activities all over the world. Monir can help you to create your Quality Management System, Technical Documentation or he can also take care of your Clinical Evaluation, Clinical Investigation through his team or partners. Easy Medical Device can also become your Authorized Representative and Independent Importer Service provider for EU, UK and Switzerland. 

Monir has around 16 years of experience within the Medical Device industry working for small businesses and also big corporate companies. He has now supported around 100 clients to remain compliant on the market. His passion to the Medical Device filed pushed him to create educative contents like, blog, podcast, YouTube videos, LinkedIn Lives where he invites guests who are sharing educative information to his audience. Visit easymedicaldevice.com to know more.  If you need help implementing QMSR or preparing your teams for FDA inspections, contact: info@easymedicaldevice.com

 If you are located outside the EU/UK/Switzerland and need an Authorized Representative (and possibly an Importer), we can support you as well.

Link

Sandy LinkedIn: https://www.linkedin.com/in/wrightsandy/

Osman Linkedin: https://www.linkedin.com/in/osman-kan/

Scarlet Linkedin: https://www.linkedin.com/company/scarlet-comply/posts/?feedView=all&viewAsMember=true

Social Media to follow

Monir El Azzouzi Linkedin: https://linkedin.com/in/melazzouzi

Twitter: https://twitter.com/elazzouzim

Pinterest: https://www.pinterest.com/easymedicaldevice

Instagram: https://www.instagram.com/easymedicaldevice

This podcast is hosted by Podcastics, the easiest platform to create and publish your podcast.

Sponsor Medboard 

Medboard: https://www.medboard.com/

EUROPE

Europe Starts Regulating the Regulators - Implementing Regulation (EU) 2026/977: https://eur-lex.europa.eu/eli/reg_impl/2026/977/oj

EUDAMED is mandatory - Panic is raising: https://health.ec.europa.eu/medical-devices-eudamed/overview_en

Germany: https://www.bfarm.de/SharedDocs/Downloads/DE/Medizinprodukte/DMIDS-anleitung-anzeigepflichtige-mp-ivd.pdf?__blob=publicationFile

Belgium: https://www.famhp.be/en/news/eudamed_clarifications_regarding_obligations_from_28_may_2026
Portugal: https://www.infarmed.pt/web/infarmed/noticias/-/journal_content/56/15786/13092901

AI Medical Devices - Timeline changed for AI ACT: https://www.consilium.europa.eu/en/press/press-releases/2026/05/07/artificial-intelligence-council-and-parliament-agree-to-simplify-and-streamline-rules/

Germany guidance: https://www.bundesnetzagentur.de/DE/Fachthemen/Digitales/KI/5_Innovationen/_DL/Roadmap_Pilot.pdf?__blob=publicationFile&v=5

Spain new HTA - Royal Decree 415/2026: https://www.boe.es/boe/dias/2026/05/29/pdfs/BOE-A-2026-11587.pdf

Denmark on languages - Reminder that there are requirements to follow: https://laegemiddelstyrelsen.dk/en/devices/registration-and-marketing/language-requirement/

UK

MHRA regulatory advice meetings - Pay and ask what you want: https://www.gov.uk/guidance/medical-devices-ask-for-a-regulatory-advice-meeting-from-the-mhra

Easy Medical Device solutions

EasyIFU - electronic Instruction for Use: https://easyifu.com

Smarteye - electronic Quality Management System: https://eqms-smarteye.com/

Rest of the World

FDA reinforce Human Factors expectations - This is not nice to have: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/content-human-factors-information-medical-device-marketing-submissions

Saudi Arabia bundling criteria - More products in a single application: https://www.sfda.gov.sa/sites/default/files/2026-05/MDS-G28.pdf

Podcast

Podcast Nostalgia - Re-listen latest podcast episodes:

Episode 390 - How can a proper intended use save your device with Kanrandeep Badwal: https://podcast.easymedicaldevice.com/390-2/

Episode 391 - Feedback after 3 months of the new FDA QMSR is in place with Mathangi Srinivasan: https://podcast.easymedicaldevice.com/391-2/

Easy Medical Device

Consulting activities (CE marking, Clinical Evaluation, QMS creation…) https://easymedicaldevice.com/services/mdr-ivdr-technical-documentation/

BOSS Program: Back Office Services

eQMS: https://easymedicaldevice.com/smarteye-eqms/

EasyIFU: eIFU and Label creation: https://easymedicaldevice.com/easyifu/

Authorized Representative in EU, UK and Switzerland

Market access all over the world: https://easymedicaldevice.com/services/market-access/

Social Media to follow

Monir El Azzouzi Linkedin: https://linkedin.com/in/melazzouzi

Twitter: https://twitter.com/elazzouzim

Pinterest: https://www.pinterest.com/easymedicaldevice

Instagram: https://www.instagram.com/easymedicaldevice

This podcast is hosted by Podcastics, the easiest platform to create and publish your podcast.

The FDA’s new Quality Management System Regulation (QMSR) officially became effective on February 2nd, 2026, replacing the legacy Quality System Regulation (QSR) framework that had been in place for nearly 30 years.

Three months later, the reality is becoming clear for many manufacturers:
QMSR is far more than a simple regulatory update.

It represents a complete transformation in how the FDA expects companies to manage quality, risk, design controls, manufacturing, supplier oversight, and post-market surveillance.

From Siloed Quality to Lifecycle Thinking

Under the old QSR framework, companies often treated quality activities separately:

Design controls

CAPA

Manufacturing

Supplier management

Post-market surveillance

QMSR changes this mindset entirely.

FDA now expects manufacturers to demonstrate integrated, risk-based quality management across the entire product lifecycle.

This means:

Design changes must connect to manufacturing validation

Supplier issues must feed into risk management

Post-market surveillance must proactively identify trends

Management reviews must show real decision-making

Why Many Companies Were Not Ready

A major misconception across the industry was believing that ISO 13485 certification automatically meant QMSR readiness.

But manufacturers are now discovering major gaps:

Incomplete Design History Files (DHF)

Weak risk integration

Poor documentation traceability

Reactive PMS systems

Limited management review evidence

FDA inspections are already reflecting these expectations.

Inspectors are requesting:

Internal audit reports

Supplier audit documentation

Management review records

Risk-based decision evidence

This level of transparency is new for many organizations.

Real-World Challenges Manufacturers Are Facing

One of the biggest pain points is DHF restructuring.

Companies with years of design changes are now being forced to reconstruct the logic behind historical decisions and organize fragmented information into a coherent, risk-based structure.

Another major shift is Post-Market Surveillance.

QMSR pushes manufacturers from reactive complaint handling toward proactive monitoring of known high-risk failure modes using trend analysis, registries, and real-world data.

Management review processes are also under greater scrutiny.
FDA now expects leadership teams to demonstrate how quality data drives actual strategic decisions.

Best Practices for QMSR Transition

Manufacturers preparing for QMSR should focus on:

1. Cross-functional collaboration

Break down silos between QA, RA, Manufacturing, Design, and Supply Chain.

2. Documentation mapping

Identify where critical design logic and risk decisions currently exist.

3. Continuous risk management

Implement ongoing cross-functional risk review meetings.

4. Stronger internal audits

Move beyond checklist auditing toward analytical risk-focused auditing.

5. Meaningful management reviews

Use management review meetings to demonstrate active leadership involvement in quality decisions.

Final Thoughts

QMSR is fundamentally changing the FDA’s expectations.

Companies that adapt early will build stronger systems, improve product quality, and reduce regulatory risk.

Companies that delay may face:

FDA 483 observations

Warning Letters

Product launch delays

Increased remediation costs

The transition to QMSR is not simply a compliance project.

It is a complete redesign of how medical device companies manage quality.

Who is Monir El Azzouzi? 

Monir El Azzouzi is the founder and CEO of Easy Medical Device a Consulting firm that is supporting Medical Device manufacturers for any Quality and Regulatory affairs activities all over the world. Monir can help you to create your Quality Management System, Technical Documentation or he can also take care of your Clinical Evaluation, Clinical Investigation through his team or partners. Easy Medical Device can also become your Authorized Representative and Independent Importer Service provider for EU, UK and Switzerland. 

Monir has around 16 years of experience within the Medical Device industry working for small businesses and also big corporate companies. He has now supported around 100 clients to remain compliant on the market. His passion to the Medical Device filed pushed him to create educative contents like, blog, podcast, YouTube videos, LinkedIn Lives where he invites guests who are sharing educative information to his audience. Visit easymedicaldevice.com to know more.  If you need help implementing QMSR or preparing your teams for FDA inspections, contact: info@easymedicaldevice.com

 If you are located outside the EU/UK/Switzerland and need an Authorized Representative (and possibly an Importer), we can support you as well.

Link

Mathangi Srinivasan linkedin: https://www.linkedin.com/in/mathangiks/

Social Media to follow

Monir El Azzouzi Linkedin: https://linkedin.com/in/melazzouzi

Twitter: https://twitter.com/elazzouzim

Pinterest: https://www.pinterest.com/easymedicaldevice

Instagram: https://www.instagram.com/easymedicaldevice

This podcast is hosted by Podcastics, the easiest platform to create and publish your podcast.

A medical device’s intended use is not just a regulatory formality — it is the foundation of the entire product strategy.

In this podcast episode, Monir El Azzouzi speaks with Karandeep Badwal about how intended use influences classification, clinical evaluation, risk management, labeling, and ultimately market access.

The discussion explores why many companies underestimate the importance of intended use and how poorly written statements can create major downstream regulatory problems. From Software as a Medical Device (SaMD) to AI-driven products, the episode highlights real-world examples where unclear intended use created challenges during certification and compliance activities.

The episode also provides practical guidance for manufacturers on:

Defining a robust intended use statement

Aligning intended use with clinical evidence and risk management

Avoiding “labeling tricks” that may trigger regulatory scrutiny

Building internal collaboration between regulatory, clinical, and product teams

This is an essential discussion for MedTech startups, QA/RA professionals, and manufacturers navigating MDR, IVDR, FDA, or global regulatory pathways.

Who is Monir El Azzouzi? 

Monir El Azzouzi is the founder and CEO of Easy Medical Device a Consulting firm that is supporting Medical Device manufacturers for any Quality and Regulatory affairs activities all over the world. Monir can help you to create your Quality Management System, Technical Documentation or he can also take care of your Clinical Evaluation, Clinical Investigation through his team or partners. Easy Medical Device can also become your Authorized Representative and Independent Importer Service provider for EU, UK and Switzerland. 

Monir has around 16 years of experience within the Medical Device industry working for small businesses and also big corporate companies. He has now supported around 100 clients to remain compliant on the market. His passion to the Medical Device filed pushed him to create educative contents like, blog, podcast, YouTube videos, LinkedIn Lives where he invites guests who are sharing educative information to his audience. Visit easymedicaldevice.com to know more.  If you need help implementing QMSR or preparing your teams for FDA inspections, contact: info@easymedicaldevice.com

 If you are located outside the EU/UK/Switzerland and need an Authorized Representative (and possibly an Importer), we can support you as well.

Link

karandeepbadwal linkedin: https://www.linkedin.com/in/karandeepbadwal/

qra-medical linkedin: https://www.linkedin.com/company/qra-medical/

Social Media to follow

Monir El Azzouzi Linkedin: https://linkedin.com/in/melazzouzi

Twitter: https://twitter.com/elazzouzim

Pinterest: https://www.pinterest.com/easymedicaldevice

Instagram: https://www.instagram.com/easymedicaldevice

This podcast is hosted by Podcastics, the easiest platform to create and publish your podcast.

Sponsor: Medboard

https://www.medboard.com/

Europe

EUDAMED: It's Go Time -May 28th 2026 for New Products: 

https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A32024R1860&qid=1720686388639

https://health.ec.europa.eu/document/download/04ce2012-97df-4dd0-8a39-d4f6993b9e16_en?filename=md_eudamed_roadmap_en.pdf

Brand new Notified Body Rules -Implementation regulation 2026/977

https://eur-lex.europa.eu/eli/reg_impl/2026/977/oj

https://www.medtecheurope.org/resource-library/new-eu-rules-more-business-predictability-and-transparency-in-medtech-conformity-assessment/

EU MDR IVDR Simplification Proposal - 2 tracks

https://www.europarl.europa.eu/RegData/docs_autres_institutions/commission_europeenne/com/2025/1023/COM_COM(2025)1023_EN.pdf

EMA Breakthrough Medical Devices Pilot  - Just launched

https://www.ema.europa.eu/en/news/new-pilot-support-development-breakthrough-medical-devices

https://www.ema.europa.eu/en/documents/presentation/presentation-breakthrough-medical-devices-pilot-information-sessio_en.pdf

MIR form update - Update your files or links:

https://health.ec.europa.eu/medical-devices-sector/new-regulations/guidance-mdcg-endorsed-documents-and-other-guidance/pmsv-reporting-forms_en

Switzerland

Swissdamed device Registration - July 1st is coming

https://www.swissmedic.ch/swissmedic/en/home/medical-devices/medizinprodukte-datenbank/produktregistrierung.html

Swissmedic's 2026 PMS Focus Campaign - Class Iia, Iib and III

https://www.swissmedic.ch/swissmedic/en/home/medical-devices/market-surveillance-of-medical-devices/schwerpunktaktionen/info-ueberpruefung-dokumentation-zur-ueberwachung-nach-inverkehrbringen.html

UK

MHRA proposes indefinite CE Mark Recognition - Poll is closed

https://www.gov.uk/government/consultations/medical-devices-regulations-targeted-consultation-on-the-indefinite-recognition-of-ce-marked-devices

New UK Clinical Trials Framework -Live Since April 28th

https://www.gov.uk/government/news/launch-of-clinical-trial-reforms

New MHRA fees + Faster Incident Reporting -  Reminder to budget and update procedures.

https://www.gov.uk/guidance/register-medical-devices-to-place-on-the-market#fees

https://www.gov.uk/government/publications/medical-devices-post-market-surveillance-requirements/vigilance-reporting-requirements

MHRA Medical Devices (Amendment) Regulations 2026 - Brand New, Your Input Needed

https://www.gov.uk/government/news/mhra-invites-views-on-proposed-changes-to-medical-device-regulation

Events

Medtech Summit - June 15-16, 2026 in Berlin, Germany

https://informaconnect.com/medtech-summit

European Medical Device Supplier Excellence Conference - June 9-11th, 2026 - Brussels, Belgium

https://medicaldevicesupplierexcellence.com/

International

USA — FDA Launches -  AI Platform HALO and Upgrades Elsa to 4.0

https://www.fda.gov/news-events/press-announcements/fda-expands-ai-capabilities-and-completes-data-platform-consolidation

Canada: Two changes happening —  Mandatory Digital Submissions + New AI/ML Device Guidance

https://www.canada.ca/en/health-canada/services/drugs-health-products/medical-devices/activities/announcements/mandatory-use-regulatory-enrolment-process-notice-to-industry.html

https://www.canada.ca/content/dam/hc-sc/documents/services/drugs-health-products/medical-devices/application-information/guidance-documents/pre-market-guidance-machine-learning-enabled-medical-devices/pre-market-guidance-machine-learning-enabled-medical-devices.pdf

Podcast

Podcast Nostalgia  

Episode 384: AI Medical Devices: What Notified Bodies Really Look for (Camille Petri): https://podcast.easymedicaldevice.com/384-2/

Episode 385: The Fake QMS Problem: Why your ISO 13485 System will fail and Audit: https://podcast.easymedicaldevice.com/385-2/

Episode 386: Life after CE Marking: Why AI Medical Devices Need Continuous Monitoring (Osman El-Kouban): https://podcast.easymedicaldevice.com/386-2/

Episode 387: Master UDI-DI: The New Layer many Medtech Companies don't Understand (Hussam Mostafa):  https://podcast.easymedicaldevice.com/387-2/

Episode 388: Certifying LLM-Driven medical devices (Sandy Wright): https://podcast.easymedicaldevice.com/388-2/

Easy Medical Device

Consulting activities (CE marking, Clinical Evaluation, QMS creation…) https://easymedicaldevice.com/services/mdr-ivdr-technical-documentation/

BOSS Program: Back Office Services

eQMS: https://easymedicaldevice.com/smarteye-eqms/

EasyIFU: eIFU and Label creation: https://easymedicaldevice.com/easyifu/

Authorized Representative in EU, UK and Switzerland

Market access all over the world: https://easymedicaldevice.com/services/market-access/

This podcast is hosted by Podcastics, the easiest platform to create and publish your podcast.

Unique Device Identification (UDI) has become a central element of medical device compliance worldwide.

From EUDAMED in Europe to FDA databases in the United States, regulators increasingly rely on accurate UDI data to improve traceability and patient safety.

But many manufacturers underestimate one important reality:

👉 A small UDI mistake can become extremely expensive.

Why UDI Accuracy Matters

UDI is not simply a number placed on a label.
It is a structured identification system connected to:

• Device traceability
• Regulatory databases
• Market surveillance
• Recalls
• Post-market monitoring

When UDI data is incorrect or incomplete, the impact can quickly spread across the entire quality and regulatory system.

The Real Risks of Incorrect UDI Data

An incorrectly calculated or poorly structured UDI can lead to:

Product Recalls

If products cannot be correctly identified, companies may need to perform recalls or field actions.

Database Errors

Incorrect submissions to EUDAMED or FDA databases may prevent customers and authorities from accessing accurate device information.

Traceability Gaps

Without proper identification, tracking affected products becomes difficult during complaints or vigilance activities.

Financial Costs

Fixing UDI errors after commercialization often requires:
• Relabeling
• Database corrections
• Regulatory updates
• Internal investigations

All of these consume significant time and resources.

Why Many Companies Struggle

UDI implementation often requires coordination between:
• Regulatory Affairs
• Quality
• Supply Chain
• IT
• Manufacturing

Many organizations discover inconsistencies in:
• Device families
• Packaging hierarchies
• Certificates
• Product configurations

Without strong governance, errors become inevitable.

Best Practices to Avoid UDI Problems

Manufacturers should:

✔ Validate UDI structures early
✔ Review regulatory guidance carefully
✔ Audit device data regularly
✔ Test database submissions before launch
✔ Ensure cross-functional ownership of UDI data

Final Thought

UDI mistakes are rarely “small” problems.

In MedTech, inaccurate identification can affect compliance, operational efficiency, and ultimately patient safety.

Who is Monir El Azzouzi? 

Monir El Azzouzi is the founder and CEO of Easy Medical Device a Consulting firm that is supporting Medical Device manufacturers for any Quality and Regulatory affairs activities all over the world. Monir can help you to create your Quality Management System, Technical Documentation or he can also take care of your Clinical Evaluation, Clinical Investigation through his team or partners. Easy Medical Device can also become your Authorized Representative and Independent Importer Service provider for EU, UK and Switzerland. 

Monir has around 16 years of experience within the Medical Device industry working for small businesses and also big corporate companies. He has now supported around 100 clients to remain compliant on the market. His passion to the Medical Device filed pushed him to create educative contents like, blog, podcast, YouTube videos, LinkedIn Lives where he invites guests who are sharing educative information to his audience. Visit easymedicaldevice.com to know more.  If you need help implementing QMSR or preparing your teams for FDA inspections, contact: info@easymedicaldevice.com

 If you are located outside the EU/UK/Switzerland and need an Authorized Representative (and possibly an Importer), we can support you as well.

Link

Sandy LinkedIn: https://www.linkedin.com/in/wrightsandy/

Scarlet Linkedin: https://www.linkedin.com/company/scarlet-comply/posts/?feedView=all&viewAsMember=true

Social Media to follow

Monir El Azzouzi Linkedin: https://linkedin.com/in/melazzouzi

Twitter: https://twitter.com/elazzouzim

Pinterest: https://www.pinterest.com/easymedicaldevice

Instagram: https://www.instagram.com/easymedicaldevice

This podcast is hosted by Podcastics, the easiest platform to create and publish your podcast.

The implementation of Unique Device Identification (UDI) has already transformed regulatory compliance in the medical device industry.

Now, Europe is introducing an additional layer: Master UDI-DI — adding both structure and complexity to the system.

Understanding the UDI Structure

To fully understand Master UDI-DI, it’s important to distinguish between the different levels:

• UDI-DI → Identifies a specific device
• Basic UDI-DI → Groups devices with the same intended purpose and characteristics
• Master UDI-DI → Applies to highly individualized devices with specific design parameters

This new layer aims to better manage products with high variability.

Why Master UDI-DI Was Introduced

For certain devices — such as spectacle frames, lenses, and other customizable products — the number of variations can become overwhelming.

Master UDI-DI helps:
• Reduce the number of identifiers required
• Improve traceability
• Simplify product grouping
• Enhance recall efficiency

Key Benefits

Despite its complexity, Master UDI-DI brings several advantages:

✔ Better organization of device data
✔ Improved market surveillance
✔ Faster identification during recalls
✔ Stronger protection against counterfeit products

Challenges for Manufacturers

However, the implementation is not without challenges:

• Increased data requirements
• Risk of incorrect UDI assignment
• Need for cross-functional coordination
• Integration with EUDAMED

As highlighted in the discussion, errors in UDI can be costly — including recalls and data inconsistencies.

Timeline and Urgency

While the labeling deadline is set for November 2028, manufacturers should not wait.

EUDAMED requirements are already active, and preparation takes time.

👉 Early implementation reduces risk, cost, and operational pressure.

Best Practices

To ensure compliance, manufacturers should:

• Study MDCG guidance documents
• Validate data before submission
• Use tools for UDI calculation
• Involve project managers and cross-functional teams
• Seek expert support when needed

Who is Al Hajj Sam Mostafa? 

Al Hajj Sam Mostafa is founder and CEO of UDI Experts. He has nearly 10 years of UDI experience, in which he leads and provides his premiere UDI solutions to MedTech organizations. One of his prestige clients is of the Magnificent Seven (Big Tech) companies. UDI Experts continuously strives to offer their clients the best UDI services for the best prices. Their global services include medical device data collection, data registration, UDI label creation and UDI label support, UDI printing IQ/OQ/PQ, and much more. 

Who is Monir El Azzouzi? 

Monir El Azzouzi is the founder and CEO of Easy Medical Device a Consulting firm that is supporting Medical Device manufacturers for any Quality and Regulatory affairs activities all over the world. Monir can help you to create your Quality Management System, Technical Documentation or he can also take care of your Clinical Evaluation, Clinical Investigation through his team or partners. Easy Medical Device can also become your Authorized Representative and Independent Importer Service provider for EU, UK and Switzerland. 

Monir has around 16 years of experience within the Medical Device industry working for small businesses and also big corporate companies. He has now supported around 100 clients to remain compliant on the market. His passion to the Medical Device filed pushed him to create educative contents like, blog, podcast, YouTube videos, LinkedIn Lives where he invites guests who are sharing educative information to his audience. Visit easymedicaldevice.com to know more.  If you need help implementing QMSR or preparing your teams for FDA inspections, contact: info@easymedicaldevice.com

 If you are located outside the EU/UK/Switzerland and need an Authorized Representative (and possibly an Importer), we can support you as well.

Link

Website: www.udiexperts.com

Business LinkedIn: www.linkedin.com/in/udi-experts-600138189           

Personal LinkedIn: www.linkedin.com/in/al-hajj-sam-m-03b69612

YouTube UDI Video for Dawa Medical  (below)

Import IQ: Episode 5 Understanding the UDI with Hussam Mustafa 

UDI Experts YouTube Channel: www.youtube.com/@UDIExperts-o3z

Social Media to follow

Monir El Azzouzi Linkedin: https://linkedin.com/in/melazzouzi

Twitter: https://twitter.com/elazzouzim

Pinterest: https://www.pinterest.com/easymedicaldevice

Instagram: https://www.instagram.com/easymedicaldevice

This podcast is hosted by Podcastics, the easiest platform to create and publish your podcast.

Achieving CE marking under the EU MDR is a major milestone for medical device manufacturers. However, for AI-based medical devices, certification is not the end of the journey — it is only the beginning.

In this episode, Osman El-Koubani shares insights into the post-market realities of AI as a Medical Device (SaMD) and what manufacturers must do to remain compliant over time.

CE Certification Is Not the Finish Line

Many companies assume that once their device is certified, the main regulatory burden is over.

In reality, Post-Market Surveillance (PMS) becomes critical — especially for AI systems that can evolve or degrade in real-world conditions.

Relaxing after certification can lead to:
• Loss of control over performance
• Undetected risks
• Regulatory non-compliance

AI in the Real World: Performance Drift

AI models often behave differently once exposed to real-world data. This phenomenon, known as performance drift, can reduce accuracy and reliability over time.

Manufacturers must implement continuous monitoring strategies, including:
• Real-world data (RWD) collection
• Performance tracking
• Feedback loops for improvement

Updating AI Devices: What Is Allowed?

Updating AI systems introduces regulatory complexity.

Key questions include:
• What qualifies as a significant change?
• Does retraining require re-certification?
• How should updates be documented and justified?

Manufacturers often struggle with these decisions, leading to compliance risks.

PCCP: Enabling Controlled Evolution

The concept of a Predetermined Change Control Plan (PCCP) allows manufacturers to define in advance how an AI system can evolve.

While this concept is gaining traction globally, its implementation in Europe is still evolving and requires careful regulatory consideration.

Building a Mature AI PMS System

A robust post-market system for AI devices should include:
• Continuous performance monitoring
• Risk management integration
• Clear documentation of updates
• Strong governance of data and models

Who is Osman El-Koubani

Dr Osman El-Koubani is a doctor and clinical researcher. With nearly a decade of experience at the intersection of healthcare, digital innovation, and AI, he has developed and implemented NHS digital solutions and advised multiple software and AI medical device startups. At Scarlet, Osman works as a Clinical Engineer and AI/ML expert, leading clinical evaluation, risk management, and usability for AI-driven medical devices, while also helping SaMD and AIaMD manufacturers navigate certification and maintain compliance through transparent, practical, and safety-focused regulatory processes.

Who is Monir El Azzouzi? 

Monir El Azzouzi is the founder and CEO of Easy Medical Device a Consulting firm that is supporting Medical Device manufacturers for any Quality and Regulatory affairs activities all over the world. Monir can help you to create your Quality Management System, Technical Documentation or he can also take care of your Clinical Evaluation, Clinical Investigation through his team or partners. Easy Medical Device can also become your Authorized Representative and Independent Importer Service provider for EU, UK and Switzerland. 

Monir has around 16 years of experience within the Medical Device industry working for small businesses and also big corporate companies. He has now supported around 100 clients to remain compliant on the market. His passion to the Medical Device filed pushed him to create educative contents like, blog, podcast, YouTube videos, LinkedIn Lives where he invites guests who are sharing educative information to his audience. Visit easymedicaldevice.com to know more.  If you need help implementing QMSR or preparing your teams for FDA inspections, contact: info@easymedicaldevice.com

 If you are located outside the EU/UK/Switzerland and need an Authorized Representative (and possibly an Importer), we can support you as well.

Link

Scarlet Linkedin: https://www.linkedin.com/company/scarlet-comply/posts/?feedView=all&viewAsMember=true

Social Media to follow

Monir El Azzouzi Linkedin: https://linkedin.com/in/melazzouzi

Twitter: https://twitter.com/elazzouzim

Pinterest: https://www.pinterest.com/easymedicaldevice

Instagram: https://www.instagram.com/easymedicaldevice

This podcast is hosted by Podcastics, the easiest platform to create and publish your podcast.

Many medical device companies believe they have a compliant Quality Management System (QMS).

On paper, everything looks perfect:
• Procedures are written
• Forms are available
• Risk management is documented
• CAPA systems are defined

But during an audit, everything falls apart.

What Is a “Fake QMS”?

A fake QMS is not necessarily incorrect — it is simply not implemented in reality.

Employees may not understand it.
Processes may not be followed.
Evidence may not exist.

In short:
👉 The system exists… but it is not alive.

Why This Happens

There are three common causes:

1. Copy-Paste Systems

Companies reuse QMS from other organizations without adapting them to their own operations.

2. Template-Based QMS

Generic ISO 13485 packages provide documentation — but no real implementation.

3. Consultant-Driven Systems

Consultants build the QMS, but knowledge is never transferred internally.

When they leave, the system collapses.

What Happens During an Audit

Auditors don’t just review documents — they test your system.

Examples include:

• CAPA: Can you explain root cause analysis?
• Risk Management: Do you link PMS data to risk updates?
• Training: Do employees understand their responsibilities?

If the answer is no, nonconformities follow.

The Core Problem

A QMS is not documentation.

👉 It is a living system based on real processes and evidence.

How to Build a Real QMS

To avoid this trap, companies should:

• Build processes based on real operations
• Keep procedures simple and usable
• Define clear responsibilities
• Train employees effectively
• Create traceable evidence
• Use an eQMS for control and integration
• Test the system internally before audits

Final Takeaway

A fake QMS is not just a compliance issue — it is a business risk.

It can lead to:
• Audit failures
• Delays in certification
• Loss of credibility

ISO 13485 is not about having documents.
👉 It’s about proving that your system works.

Who is Monir El Azzouzi? 

Monir El Azzouzi is the founder and CEO of Easy Medical Device a Consulting firm that is supporting Medical Device manufacturers for any Quality and Regulatory affairs activities all over the world. Monir can help you to create your Quality Management System, Technical Documentation or he can also take care of your Clinical Evaluation, Clinical Investigation through his team or partners. Easy Medical Device can also become your Authorized Representative and Independent Importer Service provider for EU, UK and Switzerland. 

Monir has around 16 years of experience within the Medical Device industry working for small businesses and also big corporate companies. He has now supported around 100 clients to remain compliant on the market. His passion to the Medical Device filed pushed him to create educative contents like, blog, podcast, YouTube videos, LinkedIn Lives where he invites guests who are sharing educative information to his audience. Visit easymedicaldevice.com to know more.  If you need help implementing QMSR or preparing your teams for FDA inspections, contact: info@easymedicaldevice.com

 If you are located outside the EU/UK/Switzerland and need an Authorized Representative (and possibly an Importer), we can support you as well.

Social Media to follow

Monir El Azzouzi Linkedin: https://linkedin.com/in/melazzouzi

Twitter: https://twitter.com/elazzouzim

Pinterest: https://www.pinterest.com/easymedicaldevice

Instagram: https://www.instagram.com/easymedicaldevice

This podcast is hosted by Podcastics, the easiest platform to create and publish your podcast.

Artificial Intelligence is rapidly transforming the medical device industry, enabling smarter diagnostics, predictive analytics, and personalized healthcare solutions. However, with this innovation comes increased regulatory complexity.

In this episode, Camille Petri shares insights into how Notified Bodies assess AI-based medical devices and what manufacturers need to prepare for successful certification.

Are AI Devices More Difficult to Certify?

Compared to traditional software, AI-based medical devices introduce additional layers of complexity. These include data dependency, algorithm behavior, and potential variability in performance.

Notified Bodies are therefore placing greater emphasis on transparency, traceability, and robustness.

Data: The Foundation of AI Certification

One of the most critical elements in AI certification is the quality of data.

Manufacturers must clearly document:
• Training datasets
• Validation datasets
• Test datasets

Common deficiencies include poor dataset representativeness, lack of traceability, and insufficient justification of data selection.

Clinical Evaluation for AI

Clinical evaluation for AI devices differs from traditional approaches.

Regulators may accept retrospective data in some cases, but increasingly expect strong clinical evidence demonstrating real-world performance.

The challenge lies in proving that the AI system performs consistently across different populations and use cases.

Risk Management in AI

AI introduces new types of risks, including:
• Algorithm bias
• Performance drift over time
• Lack of explainability

Manufacturers must integrate these risks into their risk management process, in line with ISO 14971.

Performance, Validation & Continuous Learning

A key question for regulators is how to manage AI systems that evolve over time.

Notified Bodies often differentiate between:
• Locked algorithms (fixed behavior)
• Continuous learning systems (adaptive models)

Each approach has different regulatory implications, particularly regarding validation and post-market monitoring.

Key Takeaway

AI in MedTech offers tremendous opportunities, but certification requires a strong foundation in data, clinical evidence, and risk management.

Understanding what Notified Bodies expect early in development can significantly improve your chances of a successful submission.

Who is Monir El Azzouzi? 

Monir El Azzouzi is the founder and CEO of Easy Medical Device a Consulting firm that is supporting Medical Device manufacturers for any Quality and Regulatory affairs activities all over the world. Monir can help you to create your Quality Management System, Technical Documentation or he can also take care of your Clinical Evaluation, Clinical Investigation through his team or partners. Easy Medical Device can also become your Authorized Representative and Independent Importer Service provider for EU, UK and Switzerland. 

Monir has around 16 years of experience within the Medical Device industry working for small businesses and also big corporate companies. He has now supported around 100 clients to remain compliant on the market. His passion to the Medical Device filed pushed him to create educative contents like, blog, podcast, YouTube videos, LinkedIn Lives where he invites guests who are sharing educative information to his audience. Visit easymedicaldevice.com to know more.  If you need help implementing QMSR or preparing your teams for FDA inspections, contact: info@easymedicaldevice.com

 If you are located outside the EU/UK/Switzerland and need an Authorized Representative (and possibly an Importer), we can support you as well.

Link

Camille Petri Linkedin: https://www.linkedin.com/in/camillepetri/

Scarlet Linkedin: https://www.linkedin.com/company/scarlet-comply/posts/?feedView=all&viewAsMember=true

Social Media to follow

Monir El Azzouzi Linkedin: https://linkedin.com/in/melazzouzi

Twitter: https://twitter.com/elazzouzim

Pinterest: https://www.pinterest.com/easymedicaldevice

Instagram: https://www.instagram.com/easymedicaldevice

This podcast is hosted by Podcastics, the easiest platform to create and publish your podcast.

Medboard

Sponsor: Medboard: https://www.medboard.com/

EU

Extension of WET Class Iib - A new list with new products mentioned: https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=PI_COM:C(2026)1809

Update your MIR form - Version 7.3.1: https://health.ec.europa.eu/document/download/e8ce9f53-82cb-44c8-a06e-91ad71c16b01_en?filename=md_new-reg_mir-form-v7.3.1_en.pdf

UK

Future Regulation -Implementation: https://www.gov.uk/government/publications/implementation-of-the-future-regulation-of-medical-devices/implementation-of-the-future-regulations

Consultation on indefinite recognition of CE marked medical devices and current transitional arrangements

Pre-market Statutory Instrument (SI)

Future Enhancemens: Exceptional Use Authorization and Health Institution exemption

Post-market Surveillance Requirements

Update to guidances

Learn Clinical Investigation in the UK - Lot of questions answered: 

Clinical investigations for electrically powered devices : https://www.gov.uk/government/publications/clinical-investigations-for-electrically-powered-devices/clinical-investigations-for-electrically-powered-devices

Clinical investigations: investigators' responsibilities : https://www.gov.uk/government/publications/clinical-investigations-investigators-responsibilities/guidance-for-clincal-investigators

Clinical investigations: statistical considerations : https://www.gov.uk/government/publications/clinical-investigations-statistical-considerations/statistical-considerations

Medical devices that need a clinical investigation: https://www.gov.uk/government/publications/medical-devices-that-need-a-clinical-investigation

Determining if Clinical Investigation is required: https://www.gov.uk/government/publications/medical-devices-that-need-a-clinical-investigation/determining-if-a-clinical-investigations-is-required

Clinical Investigation Flow chart: https://assets.publishing.service.gov.uk/media/696f850b5b6060ca6736a0ae/flow_chart_for_clinical_investigations_v3.png

Events

Team NB: Training IVDR -July 2nd 2026: https://www.team-nb.org/wp-content/uploads/2026/03/Leaflet-IVD-TD-Manufacturers-Training-20260702.pdf

Egypt: Vigilance reporting Training - April 7 to 9, 2026: https://tinyurl.com/emdpodcast

MedtechConf.com - Check the MAPEU

Swiss Medtech Day 2026 - June 10, 2026: https://medtechconf.com/event/why-swiss-medtech-day-matters-what-you-should-know/

Medtech Forum - May 11, 2026: https://medtechconf.com/event/the-medtech-forum-2026-shaping-the-future-of-medical-technology-in-europe/

US

Veeva Medtech US Summit- May 11. 2026: https://medtechconf.com/event/veeva-medtech-us-summit-2026-innovation-data-modernization-in-medical-devices/

Brazil

Hospitalar - May 19,2026: https://medtechconf.com/event/hospitalar-the-reference-event-for-healthcare-innovation-and-solutions-in-latin-america/

RoW

Australia: Software Advertisment -What to say: https://www.tga.gov.au/resources/guidance/advertising-software-based-medical-devices-australia

Your advertisement must contain:

an accurate description of the device

the trade name of the device

the intended purpose(s) of the device

any mandatory statements and, where relevant, health warnings.

For example, you must not:

claim your product is “TGA approved”

make unsubstantiated claims about the product’s performance

include endorsements or testimonials from health professionals or medical researchers.

Malaysia: Guidance Creation/Update - Medical Device Act 2012 

Guidance on Definition of Medical Devices: https://portal.mda.gov.my/index.php/announcement/1777-publication-of-second-edition-of-guidance-document-on-definition-of-medical-devices

Guidance on confirmation of obsolete and discontinued medical device: https://portal.mda.gov.my/index.php/announcement/1778-publication-of-first-edition-of-guidance-document-on-application-for-confirmation-status-of-obsolete-and-discontinued-medical-devices

Guidance on import and/or supply of unregistered medical devices under special access exemption application: https://portal.mda.gov.my/index.php/announcement/1779-publication-of-third-edition-of-guidance-document-on-import-and-or-supply-of-unregistered-medical-devices-under-special-access-exemption-application

India: FAQ on IVD products - 24 questions with answers: https://cdsco.gov.in/opencms/export/sites/CDSCO_WEB/Pdf-documents/Addendum-Doc-No-CDSCOIVDFAQ-042022dated-13032026.pdf

Egypt: What you need to register - List of documents: https://tinyurl.com/EmdEgyptRegistration

Podcast

Podcast Nostalgia -Let's remember: https://podcast.easymedicaldevice.com/

Episode 381: EUDAMED deadline 2026:  https://podcast.easymedicaldevice.com/381-2/

Episode 382: Best-of of 3 podcasts: https://podcast.easymedicaldevice.com/382-2/

Service

New Website: https://easymedicaldevice.com

Authorized Representative

Consulting

Training

EasyIFU: https://easyifu.com

Smarteye: https://eqms-smarteye.com/

This podcast is hosted by Podcastics, the easiest platform to create and publish your podcast.

The medical device industry is evolving rapidly, driven by stricter regulations, innovation, and global market challenges.
To help you stay ahead, we’ve gathered the most valuable insights from three MedTech podcasts into one concise summary.

In this article/video, we explore:

Key regulatory challenges related to FDA and MDR

Common mistakes that delay device approval

Strategic advice from industry experts

These insights highlight one essential truth: success in MedTech is not only about innovation, but also about understanding regulatory pathways and execution.

Whether you are a startup founder, regulatory professional, or industry enthusiast, these lessons will help

Social Media to follow

Monir El Azzouzi Linkedin: https://linkedin.com/in/melazzouzi

Twitter: https://twitter.com/elazzouzim

Pinterest: https://www.pinterest.com/easymedicaldevice

Instagram: https://www.instagram.com/easymedicaldevice

This podcast is hosted by Podcastics, the easiest platform to create and publish your podcast.

The upcoming EUDAMED deadline on May 28, 2026, marks a major shift in how regulatory data is managed under the EU MDR and IVDR.

While many companies believe this transition is simply about uploading documents into a European database, the reality is far more complex.

EUDAMED is not just a database — it is becoming the central regulatory infrastructure of the European medical device ecosystem, connecting manufacturers, notified bodies, regulators, and economic operators.

Why EUDAMED Matters

EUDAMED aims to increase:
• Transparency
• Traceability
• Post-market surveillance
• Regulatory oversight

To achieve this, companies must ensure that their internal data is structured, accurate, and aligned with regulatory expectations.

The Biggest Mistake

The most common misconception is treating EUDAMED as an IT project.

In reality, it is a data governance challenge.

Before uploading any device, companies must clearly define:
• Device families
• Basic UDI-DI and UDI-DI
• Certificate linkage
• Legal manufacturer responsibilities

Many organizations struggle with these fundamentals.

The 7-Step Readiness Checklist

To prepare effectively, QA/RA teams should focus on:

Actor registration (SRN)

Cleaning the device portfolio

Validating the UDI structure

Checking certificate data

Defining legacy device strategy

Assigning data ownership

Performing a dry run

Risks of Delayed Preparation

Companies that delay preparation may face:
• Incomplete or inconsistent data
• Registration delays
• Regulatory bottlenecks
• Internal confusion

EUDAMED could quickly become a regulatory traffic jam for unprepared organizations.

A Practical Timeline

To avoid these risks:

• Immediately: Audit all regulatory data
• Next 1–2 months: Validate UDI structure and device hierarchy
• Before the deadline: Perform a full readiness simulation

Final Takeaway

EUDAMED is not just a compliance requirement — it is a transformation of how regulatory information is managed in Europe.

Companies that prepare early will transition smoothly.
Those that wait may face significant delays and operational challenges.

Social Media to follow

Monir El Azzouzi Linkedin: https://linkedin.com/in/melazzouzi

Twitter: https://twitter.com/elazzouzim

Pinterest: https://www.pinterest.com/easymedicaldevice

Instagram: https://www.instagram.com/easymedicaldevice

This podcast is hosted by Podcastics, the easiest platform to create and publish your podcast.

Medboard

Sponsor: Medboard: https://www.medboard.com/

Europe

Pharmacist are distributors - French guide issued to educate them: https://medboard-public-assets.s3.amazonaws.com/Regulatory/9b892d08-611c-4326-a40e-750e0364df27.pdf

Team NB

Team NB position Paper - Reduced Scrutiny, Cost saving: https://www.team-nb.org/wp-content/uploads/2026/03/Team-NB-PositionPaper-MDR-IVDR-revision-impact-on-the-sector-20260302.pdf

Team-NB Demonstrate Safety and performance - For Combination of reagent and other equipment: https://www.team-nb.org/wp-content/uploads/2026/02/Team-NB-PositionPaper-Demonstration-of-Safety-and-Performance-for-Combinatorial-Use-of-Devices-or-Equipment-V1-20260216.pdf

Team-NB- Letter on Cybersecurity - New Proposal again: https://www.team-nb.org/wp-content/uploads/2026/02/Team-NB-Letter-on-cybersecurity-20260205.pdf

Team-NB - MDR Clinical & Tech File Training - Check the dates: https://medboard-public-assets.s3.amazonaws.com/Regulatory/442102-Leaflet-MDR-Clinical-Manufacturers-Training-20260528.pdf   and   https://www.team-nb.org/wp-content/uploads/2026/02/Leaflet-MDR-TD-Manufacturers-Training-20260429.pdf

UK

Consultation on recognizing CE mark - Should it be indefinitely: https://www.gov.uk/government/consultations/medical-devices-regulations-targeted-consultation-on-the-indefinite-recognition-of-ce-marked-devices

Consultation until: April 10, 2026

UK Reliance is ongoing - Draft proposal to recognize MDSAP and other: https://www.gov.uk/government/publications/implementation-of-the-future-regulation-of-medical-devices/statement-of-policy-intent-international-recognition-of-medical-devices

Bookmark the MHRA contact page -*Whispering* If you want to Whistleblow, there is a contact Chuuut!!!: https://www.gov.uk/guidance/contact-mhra

Solutions

EasyIFU: For eifu and Label -  Test it for Free: https://easyifu.com

Smarteye: for eQMS . Ask for a Demo: https://eqms-smarteye.com/

RoW

IMDRF

Reliance Playbook - With examples to apply: https://www.imdrf.org/sites/default/files/2026-02/IMDRF%20GRRP%20WG%20N89%20Reliance%20Playbook.pdf

USA

FDA Cybersecurity documentation - Final Guidance: https://www.fda.gov/media/119933/download

Malaysia

Launch of the Innovative Pathway - Accelerate the development of your device: https://portal.mda.gov.my/index.php/announcement/1771-implementation-of-the-innovative-medical-device-review-pathway-by-medical-device-authority-ministry-of-health-malaysia

Argentina

Self Declaration expended for Low-Risk devices - Themis platform to be used: https://www.argentina.gob.ar/noticias/entra-en-vigencia-el-nuevo-regimen-simplificado-para-la-habilitacion-de-establecimientos

Podcast

Episode 376 - Defect Management in SaMD with Anindya Mookerjea: https://podcast.easymedicaldevice.com/376-2/

Episode 377 - IEC 60601 4th edition with Leo Eisner: https://podcast.easymedicaldevice.com/377-2/
Episode 378 - IMDRF & Regulatory Reliance with Stephanie Grassmann: https://podcast.easymedicaldevice.com/378-2/

Social Media to follow

Monir El Azzouzi Linkedin: https://linkedin.com/in/melazzouzi

Twitter: https://twitter.com/elazzouzim

Pinterest: https://www.pinterest.com/easymedicaldevice

Instagram: https://www.instagram.com/easymedicaldevice

This podcast is hosted by Podcastics, the easiest platform to create and publish your podcast.

The global medical device regulatory environment is complex, often requiring manufacturers to repeat similar submissions and audits across multiple countries. This duplication slows innovation and delays patient access to life-saving technologies.

To address this challenge, international regulators are increasingly collaborating through the International Medical Device Regulators Forum (IMDRF).

In this podcast episode, Stephanie Grassmann (MedTechXperts) joins us to discuss how the concept of Regulatory Reliance is transforming global medical device approvals.

What is IMDRF?

The International Medical Device Regulators Forum (IMDRF) is a voluntary group of regulatory authorities working together to harmonize medical device regulations and reduce duplication across global markets.

Members include major regulatory bodies such as:

• United States (FDA)
• European Union
• Australia (TGA)
• Brazil (ANVISA)
• Canada (Health Canada)
• China (NMPA)

Their mission is to promote efficient regulation while maintaining high standards of safety and performance.

Understanding Regulatory Reliance

Regulatory reliance allows one authority to give significant weight to the work already performed by another trusted regulator.

Instead of repeating full assessments, authorities can leverage existing evaluations, reducing regulatory burden while maintaining confidence in safety and effectiveness.

Real-World Success Stories

Several regulators are already demonstrating the benefits of reliance mechanisms.

Australia – TGA

A Class III Mitral Valve Clip reached market access in just 20 working days after the regulator accepted evidence generated overseas.

Argentina – ANMAT

Dental instruments known as endodontic barbed broaches were approved in 9 working days using reliance pathways.

Brazil – ANVISA

Companies holding MDSAP certification may skip immediate on-site audits, saving both time and money during market entry.

These examples show how regulatory cooperation can significantly accelerate approvals.

The Role of MDSAP

The Medical Device Single Audit Program (MDSAP) allows manufacturers to undergo a single regulatory audit recognized by multiple countries.

This program plays a key role in enabling reliance between regulatory authorities and reducing redundant inspections.

The European Perspective

Europe has historically maintained a distinct regulatory framework under EU MDR and IVDR.

However, recent proposals—including references to Articles 108a and 108b—suggest increasing collaboration with international frameworks such as IMDRF and MDSAP.

While a single global approval system remains a long-term goal, reliance initiatives are already demonstrating that cooperation between regulators can improve efficiency without compromising safety.

Looking Ahead

For manufacturers and startups, embracing international regulatory frameworks early—such as MDSAP and IMDRF guidance—can significantly improve global market access strategies.

As regulatory collaboration grows, the future of medical device approvals may become faster, more harmonized, and more patient-centered.

Who is Monir El Azzouzi? 

Monir El Azzouzi is the founder and CEO of Easy Medical Device a Consulting firm that is supporting Medical Device manufacturers for any Quality and Regulatory affairs activities all over the world. Monir can help you to create your Quality Management System, Technical Documentation or he can also take care of your Clinical Evaluation, Clinical Investigation through his team or partners. Easy Medical Device can also become your Authorized Representative and Independent Importer Service provider for EU, UK and Switzerland. 

Monir has around 16 years of experience within the Medical Device industry working for small businesses and also big corporate companies. He has now supported around 100 clients to remain compliant on the market. His passion to the Medical Device filed pushed him to create educative contents like, blog, podcast, YouTube videos, LinkedIn Lives where he invites guests who are sharing educative information to his audience. Visit easymedicaldevice.com to know more.  If you need help implementing QMSR or preparing your teams for FDA inspections, contact: info@easymedicaldevice.com

 If you are located outside the EU/UK/Switzerland and need an Authorized Representative (and possibly an Importer), we can support you as well.

Link

Stephanie Grassmann Linkedin: https://www.linkedin.com/in/stephaniegrassmann-medtechxperts/

Social Media to follow

Monir El Azzouzi Linkedin: https://linkedin.com/in/melazzouzi

Twitter: https://twitter.com/elazzouzim

Pinterest: https://www.pinterest.com/easymedicaldevice

Instagram: https://www.instagram.com/easymedicaldevice

This podcast is hosted by Podcastics, the easiest platform to create and publish your podcast.

IEC 60601 has been central to medical electrical equipment safety for decades. From the prescriptive approach of the 2nd edition to the risk-based philosophy introduced in the 3rd edition, the standard has continuously evolved to address technological and regulatory complexity.

Now, the upcoming 4th edition represents more than an amendment — it signals a structural transformation.

This article explores:

The Evolution of IEC 60601

• Key shifts from the 2nd to the 3rd edition
• Why risk management became central
• What lessons shaped today’s safety philosophy

What the 4th Edition Brings

• A major rewrite rather than incremental updates
• The introduction of “atomic requirements”
• Structural clarity for manufacturers, test labs, and regulators
• Emerging technical considerations (digitalization, AI, cybersecurity, home use)

Impact on Existing Devices

• Will re-testing be required?
• How to assess validity of existing test reports
• Transition strategies with notified bodies

Integration into Design & Documentation

• Embedding IEC 60601 into risk management from day one
• Required updates in risk files, EMC documentation, labeling, and usability engineering
• Practical advice for SMEs with limited resources

The Future of IEC 60601

• Greater harmonization with ISO 14971 and IEC 62304
• Alignment with digital and AI regulatory frameworks
• The long-term outlook for medical electrical safety

For manufacturers, the message is clear:
IEC 60601 is not just a testing standard — it is a design and risk management framework that must be integrated early and strategically.

Who is Monir El Azzouzi? 

Monir El Azzouzi is the founder and CEO of Easy Medical Device a Consulting firm that is supporting Medical Device manufacturers for any Quality and Regulatory affairs activities all over the world. Monir can help you to create your Quality Management System, Technical Documentation or he can also take care of your Clinical Evaluation, Clinical Investigation through his team or partners. Easy Medical Device can also become your Authorized Representative and Independent Importer Service provider for EU, UK and Switzerland. 

Monir has around 16 years of experience within the Medical Device industry working for small businesses and also big corporate companies. He has now supported around 100 clients to remain compliant on the market. His passion to the Medical Device filed pushed him to create educative contents like, blog, podcast, YouTube videos, LinkedIn Lives where he invites guests who are sharing educative information to his audience. Visit easymedicaldevice.com to know more.  If you need help implementing QMSR or preparing your teams for FDA inspections, contact: info@easymedicaldevice.com

 If you are located outside the EU/UK/Switzerland and need an Authorized Representative (and possibly an Importer), we can support you as well.

Link

Leo Linkedin: https://www.linkedin.com/in/leoeisnersafetyconsultants/

Social Media to follow

Monir El Azzouzi Linkedin: https://linkedin.com/in/melazzouzi

Twitter: https://twitter.com/elazzouzim

Pinterest: https://www.pinterest.com/easymedicaldevice

Instagram: https://www.instagram.com/easymedicaldevice

This podcast is hosted by Podcastics, the easiest platform to create and publish your podcast.

In Software as a Medical Device (SaMD), defect management is far more than tracking bugs. It is a structured, risk-driven process that directly impacts patient safety, regulatory compliance, and product lifecycle control.

This article (and podcast episode) explores both foundational and advanced perspectives on defect management in regulated software environments.

We cover:

Understanding Defects in SaMD

• What defines a defect in a regulated context
• How defect management differs from non-medical software
• The relationship between defects, risk management, and ISO 14971

Building a Compliant Defect Management Process

• Essential documentation and tools
• Severity and priority categorization
• Handling defects discovered during validation or post-market
• Differentiating between defects, change requests, and requirement gaps

Advanced & Real-World Scenarios

• Managing safety-critical defects
• When CAPA or vigilance reporting is required
• Handling SOUP and third-party component issues
• Ensuring traceability across versions and product variants
• Agile defect management strategies

Audit Perspective & Common Pitfalls

• Frequent gaps identified by regulators and notified bodies
• How defect trend data supports CAPA and management review
• Practical advice for startups implementing lightweight but compliant systems

We also discuss how modern eQMS platforms (such as SmartEye) can help streamline documentation, automate traceability, and improve oversight without adding unnecessary bureaucracy.

Defect management in SaMD is not about documentation — it’s about maintaining control over risk and ensuring safe, effective software throughout its lifecycle.

Who is Monir El Azzouzi? 

Monir El Azzouzi is the founder and CEO of Easy Medical Device a Consulting firm that is supporting Medical Device manufacturers for any Quality and Regulatory affairs activities all over the world. Monir can help you to create your Quality Management System, Technical Documentation or he can also take care of your Clinical Evaluation, Clinical Investigation through his team or partners. Easy Medical Device can also become your Authorized Representative and Independent Importer Service provider for EU, UK and Switzerland. 

Monir has around 16 years of experience within the Medical Device industry working for small businesses and also big corporate companies. He has now supported around 100 clients to remain compliant on the market. His passion to the Medical Device filed pushed him to create educative contents like, blog, podcast, YouTube videos, LinkedIn Lives where he invites guests who are sharing educative information to his audience. Visit easymedicaldevice.com to know more.  If you need help implementing QMSR or preparing your teams for FDA inspections, contact: info@easymedicaldevice.com

 If you are located outside the EU/UK/Switzerland and need an Authorized Representative (and possibly an Importer), we can support you as well.

Link

Simon Foeger Linkedin: https://www.linkedin.com/in/simonfoeger/

Social Media to follow

Monir El Azzouzi Linkedin: https://linkedin.com/in/melazzouzi

Twitter: https://twitter.com/elazzouzim

Pinterest: https://www.pinterest.com/easymedicaldevice

Instagram: https://www.instagram.com/easymedicaldevice

This podcast is hosted by Podcastics, the easiest platform to create and publish your podcast.

SPONSOR

Medboard: https://www.medboard.com/

EUROPE

 New Harmonization Standards -  Implementing Decision 2026/193: 

https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=OJ:L_202600193

Neurosurgical implants

EN ISO 14155:2020 on clinical investigations

EN ISO 18562 series on Biocompatibility for Breathing gas pathways

Germany: Transition from DMIDS to EUDAMED - March 19, 2026:

https://www.bfarm.de/DE/Aktuelles/Veranstaltungen/Termine/2026-03-19-registrierung-mp.html?nn=986770EUDAMED mandatory by May 28th, 2026

High-Level Conference on Medical Devices - March 16th, 2026 - Brussels:

https://health.ec.europa.eu/events/high-level-conference-medical-devices-innovation-and-patient-safety-16-march-2026-brussels-belgium-2026-03-16_en

The conference will feature three breakout sessions focusing on:

Enhanced predictability for conformity assessments: combining certainty with flexibility

Clinical evidence at EU level to support the regulatory framework: the key role of Expert Panels

Breakthrough technologies for better care: turning guidance into reality

Team-NB: Letter on Cybersecurity - MDR and IVDR proposal draft version:

https://www.team-nb.org/wp-content/uploads/2026/02/Team-NB-Letter-on-cybersecurity-20260205.pdf

Switzerland

Swissmedic inspection on Importers -30 importers, 232 product samples, RESULT?:

https://www.swissmedic.ch/dam/swissmedic/en/dokumente/medizinprodukte/infos/smc-ueberprueft-ch-importeure-2025.pdf.download.pdf/md-schwerpunktaktion-importeure-2025_en.pdf

Swissdamed Webinar - May 28th, 2026:

https://www.swissmedic.ch/swissmedic/en/home/services/veranstaltungen/swissdamed-webinar.html

UK

UK to exempt Health Institution - Not a priority for now

https://www.gov.uk/government/publications/health-institution-exemption-for-general-medical-devices

Training

Team-NB: Training on MDR technical Documentation - For manufacturers on April 19th, 2026:

https://www.team-nb.org/new-session-mdr-technical-documentation-training-for-manufacturers/

EasyIFU

Create eIFU and Labels easily - Compliance to EU MDR/IVDR:

Https://easyifu.com

RoW

North America

FDA: General Wellness devices - Guidance by the FDA:

https://www.fda.gov/regulatory-information/search-fda-guidance-documents/general-wellness-policy-low-risk-devices

FDA: Cybersecurity in Medical Devices - QMS and Pre-market submission:

https://www.fda.gov/regulatory-information/search-fda-guidance-documents/cybersecurity-medical-devices-quality-management-system-considerations-and-content-premarket

APAC

Malaysia: Electronic Certificates issued by MDA - For FSC, Manufacturing Certificates and Export Certificates

https://portal.mda.gov.my/index.php/announcement/1746-implementation-of-electronic-certificates-for-certificate-of-free-sale-manufacturing-certificate-and-export-certificate-issued-by-medical-device-authority-mda-malaysia

India: Import of IVD - Online Portal: https://cdsco.gov.in/opencms/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=MTM4NDE%3D

Africa

Egypt: Database for Product Registration -Online Electronic Service: 

https://eservicesdata.edaegypt.gov.eg/MedicalDevices

Middle East

Saudi Arabia: SFDA inspection of QMS requirements - Process that would be followed:

https://www.sfda.gov.sa/sites/default/files/2026-01/MDS-REQ10E.pdf

Podcast

Episode 372 - How to remediate a Design History File (DHF): https://podcast.easymedicaldevice.com/372-2/

Episode 373 - QMSR is coming: Why FDA inspections with change completely in 2026: https://podcast.easymedicaldevice.com/373-2/

Episode 374 - Validation & Supplier Management in MedTech: https://podcast.easymedicaldevice.com/374-2/

Services

Consulting support: info@easymedicaldevice.com

Authorized Representative: EO@easymedicaldevice.com

Social Media to follow

Monir El Azzouzi Linkedin: https://linkedin.com/in/melazzouzi

Twitter: https://twitter.com/elazzouzim

Pinterest: https://www.pinterest.com/easymedicaldevice

Instagram: https://www.instagram.com/easymedicaldevice

This podcast is hosted by Podcastics, the easiest platform to create and publish your podcast.

Validation is a cornerstone of medical device compliance — yet it remains one of the most challenging areas for manufacturers. In this podcast episode, Simon Foeger, Founder of SIFO MEDICAL, shares real-world experience and practical guidance on validation, risk management, and supplier development.

Key topics discussed include:

Test Method Validation: definition, regulatory expectations, and when it is required

FDA warning letters and the risks of non-compliant validation approaches

Common pitfalls and best practices for Test Method Validation

Process Validation and Packaging Validation

The role of statistics in MedTech, including sample size justification

Risk management linked to validation activities

Supplier management, from sourcing components to audits and long-term supplier development

Simon also explains how SIFO MEDICAL supports medical device manufacturers through consulting and online training focused on:

Process validation and equipment qualification

Test Method Validation training

ISO 13485 and 21 CFR 820.30 compliance

Supply chain development, including injection molding and cleanroom manufacturing environments

This episode is essential for quality managers, regulatory professionals, validation engineers, and MedTech manufacturers looking to strengthen compliance, avoid warning letters, and build robust validation strategies.

Who is Monir El Azzouzi? 

Monir El Azzouzi is the founder and CEO of Easy Medical Device a Consulting firm that is supporting Medical Device manufacturers for any Quality and Regulatory affairs activities all over the world. Monir can help you to create your Quality Management System, Technical Documentation or he can also take care of your Clinical Evaluation, Clinical Investigation through his team or partners. Easy Medical Device can also become your Authorized Representative and Independent Importer Service provider for EU, UK and Switzerland. 

Monir has around 16 years of experience within the Medical Device industry working for small businesses and also big corporate companies. He has now supported around 100 clients to remain compliant on the market. His passion to the Medical Device filed pushed him to create educative contents like, blog, podcast, YouTube videos, LinkedIn Lives where he invites guests who are sharing educative information to his audience. Visit easymedicaldevice.com to know more.  If you need help implementing QMSR or preparing your teams for FDA inspections, contact: info@easymedicaldevice.com

 If you are located outside the EU/UK/Switzerland and need an Authorized Representative (and possibly an Importer), we can support you as well.

Link

Simon Foeger Linkedin: https://www.linkedin.com/in/simonfoeger/

Social Media to follow

Monir El Azzouzi Linkedin: https://linkedin.com/in/melazzouzi

Twitter: https://twitter.com/elazzouzim
Pinterest: https://www.pinterest.com/easymedicaldevice

Instagram: https://www.instagram.com/easymedicaldevice

This podcast is hosted by Podcastics, the easiest platform to create and publish your podcast.

For decades, medical device manufacturers in the US relied on 21 CFR 820 (QSR) — a system known for being procedural and checklist-oriented.
But starting February 2nd, 2026, FDA will implement QMSR, changing not only the regulation structure but also the inspection philosophy.

QMSR does not eliminate Part 820. Instead, FDA is amending it to incorporate ISO 13485:2016 by reference, bringing the US closer to the global quality language used across Europe, Canada, Japan, and beyond.

Why FDA is doing this

FDA’s move is driven by three key goals:

Harmonization (reduce duplicated systems and audits)

Modern quality thinking (move from “procedures” to “system effectiveness and risk”)

Inspection efficiency (more end-to-end audits)

What inspections may look like under QMSR

Instead of jumping between SOPs, inspections may follow real flows like:
Complaint → Risk Management → CAPA → Design Change → Supplier Impact
The focus becomes traceability, consistency, and risk-based justification.

What companies should do now

To be QMSR-ready, companies should:

Build an ISO 13485-style process map

Make risk visible everywhere, not only in product development

Improve CAPA triage and effectiveness checks

Strengthen design controls (especially software development & V&V)

Train teams on the new “why/how” inspection style

Who is Monir El Azzouzi? 

Monir El Azzouzi is the founder and CEO of Easy Medical Device a Consulting firm that is supporting Medical Device manufacturers for any Quality and Regulatory affairs activities all over the world. Monir can help you to create your Quality Management System, Technical Documentation or he can also take care of your Clinical Evaluation, Clinical Investigation through his team or partners. Easy Medical Device can also become your Authorized Representative and Independent Importer Service provider for EU, UK and Switzerland. 

Monir has around 16 years of experience within the Medical Device industry working for small businesses and also big corporate companies. He has now supported around 100 clients to remain compliant on the market. His passion to the Medical Device filed pushed him to create educative contents like, blog, podcast, YouTube videos, LinkedIn Lives where he invites guests who are sharing educative information to his audience. Visit easymedicaldevice.com to know more. 

📩 If you need help implementing QMSR or preparing your teams for FDA inspections, contact: info@easymedicaldevice.com

🌍 If you are located outside the EU/UK/Switzerland and need an Authorized Representative (and possibly an Importer), we can support you as well.

Social Media to follow

Monir El Azzouzi Linkedin: https://linkedin.com/in/melazzouzi

Twitter: https://twitter.com/elazzouzim

Pinterest: https://www.pinterest.com/easymedicaldevice

Instagram: https://www.instagram.com/easymedicaldevice

This podcast is hosted by Podcastics, the easiest platform to create and publish your podcast.

Design History File (DHF) remediation is rarely planned — yet it is a recurring challenge for many medical device manufacturers, especially during audits, inspections, acquisitions, or regulatory framework changes.

In this podcast episode, we provide a structured and practical discussion on:

The definition and purpose of a DHF

Key differences between FDA QMSR and ISO 13485 requirements

How the DHF concept is addressed within ISO 13485

When DHF remediation becomes unavoidable

Typical causes of remediation, including accumulated DHF debt

How to remediate a DHF without creating new compliance risks

Common pitfalls and practices to avoid

How to define a realistic and defensible remediation strategy

Regulatory communication considerations with:

National Competent Authorities

Notified Bodies

This episode is based on an article developed by Wega Informatik AG and is intended to help MedTech professionals approach DHF remediation in a controlled, transparent, and compliant way.

If you are responsible for design controls, quality systems, or regulatory compliance, this episode will help you avoid costly mistakes and build confidence in your remediation approach.

Links

Richie Christian Linkedin: https://www.linkedin.com/in/christianrichie/

https://www.wega-it.com/remediation-of-medical-device-design-history-file/

Social Media to follow

Monir El Azzouzi Linkedin: https://linkedin.com/in/melazzouzi

Twitter: https://twitter.com/elazzouzim

Pinterest: https://www.pinterest.com/easymedicaldevice

Instagram: https://www.instagram.com/easymedicaldevice

This podcast is hosted by Podcastics, the easiest platform to create and publish your podcast.

Medboard: https://www.medboard.com/

Europe

EMD Mag Issue 3 - For QA RA people: https://easymedicaldevice.com/emd-mag/

EU to simplify MDR and IVDR - Proposal ongoing: https://health.ec.europa.eu/document/download/25e7ea7c-cab3-40cf-86d9-d11f5e7744d8_en?filename=md_com_2025-1023_act_en.pdf  -  https://ec.europa.eu/commission/presscorner/api/files/document/print/en/qanda_25_3078/QANDA_25_3078_EN.pdf  -  https://ec.europa.eu/commission/presscorner/api/files/attachment/882087/FACTSHEET%20medical%20devices%20final%20(1).pdf

Team NB Position Paper on Annex VII - Not agreeing all EU Proposal: https://www.team-nb.org/wp-content/uploads/2025/12/Team-NB-PositionPaper-Annex-VII-V1-20251216.pdf

MDCG 2025-9 Learn Breakthrough Devices BtX - Guidance for innovative products: https://health.ec.europa.eu/document/download/edca94c7-62ab-4dd5-8539-2b347bd14809_en?filename=mdcg_2025-9.pdf

Infographic: https://www.linkedin.com/posts/melazzouzi_medtech-mdr-ivdr-activity-7414590943179202560-jbxH?utm_source=share&utm_medium=member_desktop&rcm=ACoAAABZ07ABDocaBMTLJo8bsl8V3bgNSBIiZuI

MDCG 2025-10 on PMS - Learn how to do it with this guidance: https://health.ec.europa.eu/document/download/a9ad86b7-1b8e-4bae-beb4-48b2b3ed2f05_en?filename=mdcg_2025-10_en.pdf

Notified Body Malta Conformity Assessment - 52nd Notified Body for MDR: https://webgate.ec.europa.eu/single-market-compliance-space/notified-bodies/notifications?organizationRefeCd=SIMS_INPUT_282916&filter=notificationStatusId:1 

Services

EasyIFU - Manage your eIFU and Labels: https://easyifu.com

Switzerland

Swissdamed registration deadline - July 1st 2026: https://www.swissmedic.ch/swissmedic/en/home/medical-devices/medizinprodukte-datenbank/swissdamed-informationen/frist-produktregistrierung-in-swissdamed.html - https://swissdamed-webinar.ch/#E402A0

UK

MHRA Price changing -: More cost for manufacturers: https://www.gov.uk/guidance/register-medical-devices-to-place-on-the-market#fees

RoW

FDA: How to use Real World Evidence - Guidance Document offered: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/use-real-world-evidence-support-regulatory-decision-making-medical-devices

Australia: Preparing for UDI and AusUDID - Checklist for preparation available: https://www.tga.gov.au/sites/default/files/2025-12/preparing-for-udi-in-australia-checklist_0.pdf

Podcast

Podcast Nostalgia - What was discussed lastly: 

Episode 367 - From Engineer to Clinical Evaluation Expert - Florian Tolkmitt: https://podcast.easymedicaldevice.com/367-2/

Episode 368 - Simplifying EU MDR IVDR with Adam Isaacs Rae: https://podcast.easymedicaldevice.com/368-2/

Episode 369 - Last Podcast of the Year: https://podcast.easymedicaldevice.com/369-2/

Episode 370 - Verification & Validation with Aaron Joseph: https://podcast.easymedicaldevice.com/370-2/

This podcast is hosted by Podcastics, the easiest platform to create and publish your podcast.

Verification & Validation (V&V) plays a central role in ensuring that medical devices are safe, effective, and compliant — yet it remains one of the most challenging phases for many teams.

In this podcast episode, we sit down with Aaron Joseph, medical device development expert and author of the well-known article “Top 10 V&V Fails”, to explore why V&V so often becomes a source of stress — and how teams can do better.

Throughout the discussion, we cover:

A clear, simple explanation of Verification vs. Validation

Why V&V must span the entire development lifecycle

How poor requirements create downstream V&V failures

The risks of starting V&V planning too late

How to simplify test methods without losing rigor

Practical strategies for handling failed tests

How to think about traceability without fear

The future of V&V as software and AI become more prevalent

This episode is designed to educate, demystify, and inspire QA/RA professionals, engineers, and MedTech leaders looking to build stronger, more resilient development processes.

Who is Monir El Azzouzi?

Monir El Azzouzi is a Medical Device Expert specializing in Quality and Regulatory Affairs. After working for many years with big Healthcare companies, particularly Johnson and Johnson, he decided to create EasyMedicalDevice.com to help people better understand Medical Device Regulations worldwide. He has now created the consulting firm Easy Medical Device GmbH and developed many ways to deliver knowledge through videos, podcasts, online courses… His company also acts as Authorized Representative for the EU, UK, and Switzerland. Easy Medical Device becomes a one-stop shop for medical device manufacturers that need support on Quality and Regulatory Affairs.

Social Media to follow

Aaron Joseph Linkedin: https://www.linkedin.com/in/ajosephprofile/

Monir El Azzouzi Linkedin: https://linkedin.com/in/melazzouzi

Twitter: https://twitter.com/elazzouzim

Pinterest: https://www.pinterest.com/easymedicaldevice

Instagram: https://www.instagram.com/easymedicaldevice

This podcast is hosted by Podcastics, the easiest platform to create and publish your podcast.

As the year closes, this special podcast episode offers a comprehensive overview of what happened at Easy Medical Device in 2025 and the key priorities shaping 2026.

The episode reflects on a full year of continuous content creation, including:

Weekly podcast episodes covering global medical device regulations

Increased focus on artificial intelligence and its impact on QA/RA roles

Educational initiatives such as EMD Mag, designed to make complex regulatory topics more accessible

Development of digital tools like EasyIFU, labeling automation, and eQMS solutions

Expansion of consulting, back-office services, and international presence

The discussion also addresses upcoming challenges:

Increasing pressure on Notified Bodies

Risks for late MDR/IVDR transitions

The importance of anticipation and regulatory strategy for new and existing manufacturers

More than a recap, this episode is a strategic pause — an opportunity to reflect, learn, and prepare for the years ahead in a rapidly evolving medtech regulatory environment.

Who is Monir El Azzouzi?

Monir El Azzouzi is a Medical Device Expert specializing in Quality and Regulatory Affairs. After working for many years with big Healthcare companies, particularly Johnson and Johnson, he decided to create EasyMedicalDevice.com to help people better understand Medical Device Regulations worldwide. He has now created the consulting firm Easy Medical Device GmbH and developed many ways to deliver knowledge through videos, podcasts, online courses… His company also acts as Authorized Representative for the EU, UK, and Switzerland. Easy Medical Device becomes a one-stop shop for medical device manufacturers that need support on Quality and Regulatory Affairs.

Social Media to follow

Monir El Azzouzi Linkedin: https://linkedin.com/in/melazzouzi

Twitter: https://twitter.com/elazzouzim

Pinterest: https://www.pinterest.com/easymedicaldevice

Instagram: https://www.instagram.com/easymedicaldevice

This podcast is hosted by Podcastics, the easiest platform to create and publish your podcast.

The European medical device sector is a vital pillar of healthcare innovation, employing over 930,000 people and representing a market of approximately €170 billion. However, since the implementation of MDR and IVDR, manufacturers—especially SMEs—have faced increasing regulatory complexity, long certification timelines, and reduced market predictability.

In this podcast episode, we explore the 2025 EU proposal designed to address these challenges by simplifying regulatory processes while preserving patient safety.

The discussion covers:

Key shortcomings of the current MDR/IVDR framework

The impact on innovation, availability of devices, and SMEs

The eight reform pillars, including proportionality, digitalisation, international cooperation, and improved coordination with EMA and Notified Bodies

How upcoming EU legislation (AI Act, Cybersecurity Act, Biotech Act) will interact with medical device regulations

This episode provides practical insights for manufacturers, regulatory professionals, and policymakers seeking to anticipate regulatory changes and adapt their strategies accordingly.

Who is Monir El Azzouzi?

Monir El Azzouzi is a Medical Device Expert specializing in Quality and Regulatory Affairs. After working for many years with big Healthcare companies, particularly Johnson and Johnson, he decided to create EasyMedicalDevice.com to help people better understand Medical Device Regulations worldwide. He has now created the consulting firm Easy Medical Device GmbH and developed many ways to deliver knowledge through videos, podcasts, online courses… His company also acts as Authorized Representative for the EU, UK, and Switzerland. Easy Medical Device becomes a one-stop shop for medical device manufacturers that need support on Quality and Regulatory Affairs.

Links 

 Adam Linkedin: https://www.linkedin.com/in/adam-isaacs-rae/

Social Media to follow

 Monir El Azzouzi Linkedin: https://linkedin.com/in/melazzouzi

 Twitter:

https://twitter.com/elazzouzim

 Pinterest: https://www.pinterest.com/easymedicaldevice

 Instagram: https://www.instagram.com/easymedicaldevice

This podcast is hosted by Podcastics, the easiest platform to create and publish your podcast.

Clinical Evaluation has become one of the most critical — and challenging — domains under the EU MDR. But how does one build real expertise in this field?

In this episode of the Medical Device Made Easy podcast, Monir El Azzouzi interviews Florian Tolkmitt, Clinical Evaluation Expert at Pro-Liance, to explore his journey from engineering into clinical evaluation and regulatory science.

The discussion covers:

Florian’s education and early career path

How he specialized in Clinical Evaluation

Key lessons learned since the implementation of the EU MDR

What Notified Bodies really expect from clinical documentation

Frequent mistakes manufacturers make in clinical submissions

The evolving role of consultants in supporting compliance

How AI and digital tools may transform literature review and evidence generation

Advice for young professionals entering the MedTech field

This episode offers practical insights, career inspiration, and forward-looking perspectives for anyone working — or aspiring to work — in clinical evaluation and regulatory affairs.

Who is Monir El Azzouzi?

Monir El Azzouzi is a Medical Device Expert specializing in Quality and Regulatory Affairs. After working for many years with big Healthcare companies, particularly Johnson and Johnson, he decided to create EasyMedicalDevice.com to help people better understand Medical Device Regulations worldwide. He has now created the consulting firm Easy Medical Device GmbH and developed many ways to deliver knowledge through videos, podcasts, online courses… His company also acts as Authorized Representative for the EU, UK, and Switzerland. Easy Medical Device becomes a one-stop shop for medical device manufacturers that need support on Quality and Regulatory Affairs.

Links

Linkedin florian: https://www.linkedin.com/in/florian-tolkmitt-clinical-evaluation/

Social Media to follow

Monir El Azzouzi Linkedin: https://linkedin.com/in/melazzouzi

Twitter: https://twitter.com/elazzouzim

Pinterest: https://www.pinterest.com/easymedicaldevice

Instagram: https://www.instagram.com/easymedicaldevice

This podcast is hosted by Podcastics, the easiest platform to create and publish your podcast.

Medboard

Europe

48% disruption in the EU - I hope you are all healthy: https://health.ec.europa.eu/document/download/13b2c812-b144-4489-af1f-e76af5bc97fd_en?filename=md_availability_study_presentation_2024.pdf

Consultation: SCHEER asks you - Are Brain Stimulators for non-medical purpose dangerous: https://health.ec.europa.eu/consultations/scheer-public-consultation-preliminary-scientific-opinion-health-hazards-and-risks-associated-use_en

Q&A Medicines used with Medical Devices - Revision 6 with new questions: https://www.ema.europa.eu/en/documents/regulatory-procedural-guideline/questions-answers-implementation-medical-devices-vitro-diagnostic-medical-devices-regulations-eu-2017-745-eu-2017-746_en.pdf

EUDAMED is Mandatory - From 28 May 2026: https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=OJ:L_202502371 - https://health.ec.europa.eu/latest-updates/eudamed-four-first-modules-will-be-mandatory-use-28-may-2026-2025-11-27_en

UK

Better Call MHRA - But we don't consult: https://www.gov.uk/guidance/medical-devices-get-regulatory-advice-from-the-mhra

Standard

ISO 10993-1 mutation - Nothing is automatic anymore: https://www.youtube.com/watch?v=AkSZVNSz5a0

ISO 18969 draft -  Comments until 28-01-2026: https://www.youtube.com/watch?v=zCR9HlHJ5l0

EasyIFU

Create your Labels with EasyIFU - UDI included: https://easyifu.com

Rest of the World

Argentina

Argentina: Simplified application - Class I/A or Class II/B: https://www.argentina.gob.ar/noticias/anmat-establece-un-regimen-simplificado-para-la-habilitacion-de-establecimientos

Canada

Canada: Modernization of the MDEL - Some changes: https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/establishment-licences/medical-devices-compliance-bulletin/consultation-modernizing-mdel-framework-phase-ii.html

Canada: Medical Device License Application - Guidance on how to do it: https://www.canada.ca/en/health-canada/services/drugs-health-products/medical-devices/application-information/guidance-documents/managing-applications-licenses.html

Brazil

Brazil: Digitalisation of Certificates - You can request that online now: https://www.gov.br/anvisa/pt-br/assuntos/noticias-anvisa/2025/anvisa-lanca-nova-ferramenta-para-emitir-certificados-de-dispositivos-medicos

Podcast

Podcast Nostalgia - Let's review previous podcasts

Episode 363 - The journey of a CRO with Helene Quie: https://podcast.easymedicaldevice.com/363-2/

Episode 364 - What is changing with the new ISO 10993-1 with Marina Daineko: https://podcast.easymedicaldevice.com/364-2/

Episode 365 - How to become a Lead Auditor with Rob Packard: https://podcast.easymedicaldevice.com/365-2/

Social Media to follow

Monir El Azzouzi Linkedin: https://linkedin.com/in/melazzouzi

Twitter: https://twitter.com/elazzouzim

Pinterest: https://www.pinterest.com/easymedicaldevice

Instagram: https://www.instagram.com/easymedicaldevice

This podcast is hosted by Podcastics, the easiest platform to create and publish your podcast.

Becoming a Lead Auditor is one of the most valuable career steps for quality and regulatory professionals in the MedTech sector. Lead Auditors play a critical role in evaluating QMS performance, improving compliance, and preparing organizations for ISO certification.

In this podcast episode, we explore:

🔹 What is a Lead Auditor?

The responsibilities, authority, and role differences between internal audits, supplier audits, and certification audits.

🔹 Who can become a Lead Auditor?

The competencies required, background expectations, and what makes a good auditor.

🔹 What you must learn to be effective:

ISO 19011 — the core auditing guideline

ISO 13485 — the medical device QMS standard

ISO 14971 — risk management for medical devices

Software lifecycle & technical documentation considerations

🔹 Do Lead Auditor certificates expire?

Clarifying the myth around renewal, competency maintenance, and the expectations of certification bodies.

🔹 Spotlight: Lead Auditor Training by Medical Device Academy

We review the upcoming training course, covering:

Curriculum and learning objectives

Exam format

Prerequisites

Pricing

Training dates

Certificate details

👉 Learn more or register here: https://medicaldeviceacademy.com/lead-auditor-training/

This episode is ideal for QA/RA specialists, QMS managers, consultants, and anyone aiming to take a leadership role in medical device auditing.

Who is Monir El Azzouzi?

Monir El Azzouzi is a Medical Device Expert specializing in Quality and Regulatory Affairs. After working for many years with big Healthcare companies, particularly Johnson and Johnson, he decided to create EasyMedicalDevice.com to help people better understand Medical Device Regulations worldwide. He has now created the consulting firm Easy Medical Device GmbH and developed many ways to deliver knowledge through videos, podcasts, online courses… His company also acts as Authorized Representative for the EU, UK, and Switzerland. Easy Medical Device becomes a one-stop shop for medical device manufacturers that need support on Quality and Regulatory Affairs.

Social Media to follow

Monir El Azzouzi Linkedin: https://linkedin.com/in/melazzouzi

Twitter: https://twitter.com/elazzouzim

Pinterest: https://www.pinterest.com/easymedicaldevice

Instagram: https://www.instagram.com/easymedicaldevice

This podcast is hosted by Podcastics, the easiest platform to create and publish your podcast.

The long-awaited revision of ISO 10993-1 is almost here – and the MedTech community is full of questions.
Will we need to retest everything?
Is this a complete game-changer, or just an evolution?
How will Notified Bodies and the FDA react?

In this episode of the Medical Device Made Easy Podcast, Monir El Azzouzi hosts Marina Daineko, biocompatibility consultant at Intrinsic Medical Group, to unpack what’s really coming.

This episode covers:

The background and current status of the ISO 10993-1 revision

Why the new version is best seen as an evolution, not a revolution

How the standard pushes further into a risk-based, scientifically justified approach

The link with ISO 14971 and lifecycle thinking

Changes in contact categorization and cumulative exposure

The industry trend toward reducing animal testing through in vitro methods and data-driven justification

How to conduct a gap analysis once the new standard is published

Practical advice on how to prioritize updates without freezing projects or panicking

Real-world examples where process chemicals, not base materials, changed the risk picture

How Intrinsic Medical Group supports companies with biological evaluation, cleanliness, sterilization and reusable devices

👉 If you’re involved in RA/QA, R&D, toxicology, or clinical development, this conversation gives you a practical roadmap for navigating the transition to the new ISO 10993-1.

Who is Monir El Azzouzi?

Monir El Azzouzi is a Medical Device Expert specializing in Quality and Regulatory Affairs. After working for many years with big Healthcare companies, particularly Johnson and Johnson, he decided to create EasyMedicalDevice.com to help people better understand Medical Device Regulations worldwide. He has now created the consulting firm Easy Medical Device GmbH and developed many ways to deliver knowledge through videos, podcasts, online courses… His company also acts as Authorized Representative for the EU, UK, and Switzerland. Easy Medical Device becomes a one-stop shop for medical device manufacturers that need support on Quality and Regulatory Affairs.

Links

Marina Daineko Linkedin: https://www.linkedin.com/in/marinadaineko/

Intrinsic Medical Group, LLC: https://www.linkedin.com/company/intrinsic-medical-group/posts/?feedView=all

Social Media to follow

Monir El Azzouzi Linkedin: https://linkedin.com/in/melazzouzi

Twitter: https://twitter.com/elazzouzim

Pinterest: https://www.pinterest.com/easymedicaldevice

Instagram: https://www.instagram.com/easymedicaldevice

This podcast is hosted by Podcastics, the easiest platform to create and publish your podcast.

In this long-form interview, Helene Quie, founder of Qmed Consulting, shares an inside look at nearly 20 years of experience in clinical and regulatory consulting for medical devices.

This article covers:

• Helene’s personal journey from employee to entrepreneur
• The early risks and decisions that shaped Qmed’s growth
• How the company’s services and markets evolved over time
• A deep dive into clinical evidence generation vs equivalence
• The seismic impact of EU MDR on clinical strategies
• PMCF pitfalls and real-life examples
• Working with Notified Bodies and new expectations under MDR
• Lessons from projects that didn’t go as planned
• The crucial alignment between clinical data and human factors
• Practical advice for startups on avoiding top regulatory mistakes
• Her vision of the future: RWE, adaptive study designs, digital health & greater regulatory convergence

Links:

Helene Quie: https://www.linkedin.com/in/helene-quie-863a323/

Qmed Consulting: https://qmed-consulting.com/

Who is Monir El Azzouzi?

Monir El Azzouzi is a Medical Device Expert specializing in Quality and Regulatory Affairs. After working for many years with big Healthcare companies, particularly Johnson and Johnson, he decided to create EasyMedicalDevice.com to help people better understand Medical Device Regulations worldwide. He has now created the consulting firm Easy Medical Device GmbH and developed many ways to deliver knowledge through videos, podcasts, online courses… His company also acts as Authorized Representative for the EU, UK, and Switzerland. Easy Medical Device becomes a one-stop shop for medical device manufacturers that need support on Quality and Regulatory Affairs.

Social Media to follow

Monir El Azzouzi Linkedin: https://linkedin.com/in/melazzouzi

Twitter: https://twitter.com/elazzouzim

Pinterest: https://www.pinterest.com/easymedicaldevice

Instagram: https://www.instagram.com/easymedicaldevice

This podcast is hosted by Podcastics, the easiest platform to create and publish your podcast.

MedBoard

EU

Joint clinical assessment procedure -  EU 2025/2086 regulation for reimbursement in the EU: https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=OJ:L_202502086

Team-NB position paper on Companion diagnostics - Significant changes rules: https://www.team-nb.org/wp-content/uploads/2025/10/Team-NB-PositionPaper-IVDR-Significant-changes-V2.pdf

MDR and IVDR put at risk transplantation - Donor Screening and SoHo preparation: https://www.edqm.eu/documents/52006/162284/PA-PH-TO%20%2824%29%2018%20%E2%80%93%20Risks%20to%20safety%20and%20quality%20in%20donor%20screening%20and%20SoHO%20preparations%20due%20to%20poor%20implementation%20of%20the%20MDR%20and%20IVDR%20%E2%80%93%20CD-P-TO%20Position%20paper%20%E2%80%93%20October%202025.pdf/51d5efb2-4611-13ad-76a0-b5710b371248

Dedicated proportionate regulatory pathway for Niche fields

Article 5(5.g) requirements to the highest risk categories (Health institutions to create documentation for the products)

Update of MDCG guidance on In-house devices to better reflect the operational reality.

Off-label use and RUO are not falling on Article 5.5 so grey zone.

Team-NB proposal for MDR & IVDR - 5 topics on the agenda:  https://www.team-nb.org/nbs-views-on-mdr-and-ivdr-review-process/

Early dialogue: Use of this to talk to Notified Bodies

Article 61.10 & WET: Update for more clarity. Narrow the scope.

Digitalisation: Machine readable documents, AI to support simulations to reduce Animal testing.

Coding for MD and IVD

Designation and recertification: For Notified Bodies

Breakthrough: Coordinated pathway with challenge to generate Clinical Data.

Notified Bodies Count - S New comers for MDR and IVDR: 

SGS Fimko oy (IVDR 19): https://webgate.ec.europa.eu/single-market-compliance-space/notified-bodies/notifications/1016921

ICIM S.P.A. (MDR 51) : https://webgate.ec.europa.eu/single-market-compliance-space/notified-bodies/notifications?organizationRefeCd=EPOS_43747&filter=notificationStatusId:1

Notice (MDR): https://webgate.ec.europa.eu/single-market-compliance-space/notified-bodies/notifications/1020121

Standards

New Harmonized Standards - Clothing and sterilisers: https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=OJ:L_202502078

Biocompatibility

ISO TS 23485: https://www.linkedin.com/posts/melazzouzi_iso13485-iso-medicaldevice-activity-7393773266689228801-d7LM?utm_source=share&utm_medium=member_desktop&rcm=ACoAAABZ07ABDocaBMTLJo8bsl8V3bgNSBIiZuI

UK Reliance with US FDA - Harmonization is ongoing: https://www.gov.uk/government/news/patients-to-benefit-as-uk-and-us-regulators-forge-new-collaboration-on-medical-technologies-and-ai

Service

eIFU with free access -Test it and let us know : https://Easyifu.com

eQMS for a structured Quality Management System - Get your demo: https://eqms-smarteye.com/

Magazine

eMagazine . EMD Mag Free- Are Notified Bodies still the right model: https://easymedicaldevice.com/emd-mag/

ROW

US FDA: Pre-RFD -:Combination product: https://www.fda.gov/media/189466/download

US FDA: QMSR guidelines -: How to create a QMS: https://www.fda.gov/media/189345/download

PODCAST

Podcast review -  What happened in October 2025

Episode 357 - Highlights from La Rentrée du DM 2025: https://podcast.easymedicaldevice.com/357-2/

Episode 358 - Clinical Evidence under EU MDR - Why so many dossier fail (And how to fix it): https://podcast.easymedicaldevice.com/358-2/

Episode 359 - Real World Evidence - How to use it right for FDA and EU: https://podcast.easymedicaldevice.com/359-2/

Episode 360: US Government Shutdown - What FDA can still be doing? Rob Packard: https://podcast.easymedicaldevice.com/360-2/

Episode 361 - Automatisation of your QA RA Job with AI - Hatem Rabeh:  https://podcast.easymedicaldevice.com/361-2/

This podcast is hosted by Podcastics, the easiest platform to create and publish your podcast.

Artificial Intelligence is reshaping the world of Quality and Regulatory Affairs.
In this podcast episode, Hatem Rabeh joins to demystify how AI can be used — and where it must be handled carefully.

We discuss:

The reality behind “AI replacing QA/RA jobs”

Key tools: n8n, Make, Zapier, OpenAI, and OpenFDA

Building automation workflows for regulatory monitoring and documentation

Managing data privacy, confidentiality, and local vs cloud solutions

The cost, setup time, and risks of AI hallucination

How to use AI safely and ethically in regulated environments

👉 By the end, you’ll know how to build smart workflows that save time, ensure compliance, and keep human oversight where it matters most.

Who is Monir El Azzouzi?

Monir El Azzouzi is a Medical Device Expert specializing in Quality and Regulatory Affairs. After working for many years with big Healthcare companies, particularly Johnson and Johnson, he decided to create EasyMedicalDevice.com to help people better understand Medical Device Regulations worldwide. He has now created the consulting firm Easy Medical Device GmbH and developed many ways to deliver knowledge through videos, podcasts, online courses… His company also acts as Authorized Representative for the EU, UK, and Switzerland. Easy Medical Device becomes a one-stop shop for medical device manufacturers that need support on Quality and Regulatory Affairs.

Social Media to follow

Monir El Azzouzi Linkedin: https://linkedin.com/in/melazzouzi

Twitter: https://twitter.com/elazzouzim

Pinterest: https://www.pinterest.com/easymedicaldevice

Instagram: https://www.instagram.com/easymedicaldevice

This podcast is hosted by Podcastics, the easiest platform to create and publish your podcast.